Page last updated: 2024-08-23

etoposide and Ovarian Neoplasms

etoposide has been researched along with Ovarian Neoplasms in 481 studies

Research

Studies (481)

Timeframe	Studies, this research(%)	All Research%
pre-1990	52 (10.81)	18.7374
1990's	195 (40.54)	18.2507
2000's	127 (26.40)	29.6817
2010's	87 (18.09)	24.3611
2020's	20 (4.16)	2.80

Authors

Authors	Studies
Bastow, KF; Cheng, HH; Ito, J; Lee, KH; Luo, TY; Nakanishi, Y; Tachibana, Y; Wang, HK; Xu, Z	1
Bauersachs, J; Cornberg, M; Kempf, T; Koenig, T; Schäfer, A; Schultheiss, HP	1
Chu, J; Ma, X; Shao, J; Wang, T; Yao, R; Yu, Z; Zhu, H	1
Barathi, D; Dahagama, S; Dubashi, B; Ganesan, P; Goenka, L; Kayal, S; Krishnamoorthy, N; Mathaiyan, J; Nakka, T; Thumaty, DB	1
Blanc, E; Chabaud, S; Dijoud, F; Dumesnil, C; Faure-Conter, C; Flechon, A; Fresneau, B; Hameury, F; Mansuy, L; Orbach, D; Renard, M; Rome, A; Sudour-Bonnange, H; Thebaud, E; Verité, C	1
Chen, W; Cheng, Z; Ma, X; Zhang, Q	1
Che, Y; Chen, J; Chen, Z; Cheng, X; Chu, R; Huang, C; Jiang, J; Kong, B; Li, J; Li, K; Li, L; Liu, P; Pan, X; Song, K; Song, L; Wang, J; Xue, Y; Yao, S; Zhang, X; Zhao, Y	1
Ackermann, MK; Alexiadis, M; Armour, NE; Chu, S; Eroh, KD; Fuller, PJ; Jobling, TW; Langdale, LM; Rodgers, S; White, VM	1
Aguiar, X; Bergamini, A; Fotopoulou, C; Froeling, F; Kaur, B; Papanastasopoulos, P; Ramaswami, R; Rustin, GJS; Sarwar, N; Saso, S; Savage, PM; Seckl, M; Sharma, A; Short, D	1
Aleshawi, AJ; Alhowary, A; Altal, OF; Tashtush, NA	1
Dandulakis, M; Mayer, R; Richards, S; Roque, DM; Staats, PN	1
Aghajanian, C; Gordon, S; Grisham, RN; Iyer, GV; Moore, K; Temkin, SM; Wise, HC	1
Chen, L; Cui, L; Gao, M; He, K; He, M; Jia, Y; Li, J; Pan, Y; Shao, D; Shi, T; Yang, X; Yue, F; Zhang, M; Zhao, Y; Zheng, X	1
Baek, MH; Choi, MC; Chung, YS; Kang, S; Kim, MK; Kim, SI; Kim, YM; Kwon, BS; Lee, JW; Lee, KB; Lee, SH; Lee, SJ; Park, BK; Seong, SJ; Shim, SH; Song, T; Yoo, HJ	1
Cai, S; Li, H; Sun, L; Wu, L; Yang, M; Zhang, X; Zhang, Y	1
Alexandre, J; Bello-Roufai, D; Berton, D; Blanc-Durand, F; Chaltiel, D; Collard, O; Dupre, PF; Fabbro, M; Faller, É; Floquet, A; Genestie, C; Guillemet, C; Hardy-Bressard, AC; Kalbacher, E; Lefeuvre-Plesse, C; Meriaux, É; Pautier, P; Provansal, M; Ray-Coquard, I	1
Noda, T; Oyama, T; Shimada, A; Washio, K	1
Chen, L; Gao, M; He, K; Li, J; Pan, Y; Shao, D; Shi, T; Yang, X; Zhang, F; Zhang, M; Zhao, J; Zhao, Y; Zheng, X	1
Chuma, M; Goda, M; Hamada, Y; Hamano, H; Hayama, T; Horinouchi, Y; Ikeda, Y; Imai, T; Ishida, S; Ishizawa, K; Kirino, Y; Mitsuhashi, C; Nakamura, T; Niimura, T; Okada, N; Sakamoto, K; Shinomiya, K; Suzuki, Y; Takechi, K; Tsujinaka, K; Yagi, K; Yanagawa, H; Zamami, Y	1
Chen, TC; Dai, SH; Tsai, WH; Zeng, YH	1
Gan, F; He, Y; Li, S; Luo, M; Luo, P; Xie, B; Zhang, S	1
Chauhan, R; Khurana, S; Kumar, L; Kumar, S; Malik, PS; Mathur, S; Sharma, A; Singh, M; Sreenivas, V	1
Alrjoub, MM; Alshriedeh, O; Amarin, Z; Sindiani, A	1
Arık, Z; Bozkaya, Y; Demirci, U; Doğan, M; Tulunay, G; Umut Erdem, G; Uncu, H; Yazıcı, O; Zengin, N	1
Barretta, F; Basso, ME; Biasoni, D; Bisogno, G; Boldrini, R; Boschetti, L; Cecchetto, G; Conte, M; D'Angelo, P; De Leonardis, F; De Pasquale, MD; Di Pinto, D; Inserra, A; Siracusa, F; Spreafico, F; Terenziani, M	1
Adbul-Karim, F; Link, N; Michener, CM; Radeva, M; Rose, PG	1
Ben Hassouna, J; Bouzaiene, H; Ghalleb, M; Hadiji, A; Hechiche, M; Rahal, K; Slim, S	1
Li, B; Li, SM; Wu, LY; Zhang, GY; Zhang, R	1
Clamp, AR; Hasan, J; Jayson, GC; Mescallado, N; Mitchell, C; Morgan, RD; Saunders, G; Welch, R	1
Cuadra, M; Lapuente-Ocamica, O; Lete, I; Lopez-Picado, A; Maestro, L; Ugarte, L	1
Feng, YL; Huang, HQ; Huang, X; Lan, CY; Li, JD; Li, YF; Liu, Q; Shen, JX; Wang, Y; Xiong, Y; Zhang, YN; Zheng, M	1
Gourley, C	1
Ismail, H; Khan, RS; Saba, A	1
Li, B; Song, Y; Zhang, Y; Zhao, D	1
Ballester, ML; Berástegui, E; Llavayol, M; Pons, M	1
Ahmad, A; Banerjee, S; Berney, DM; Graham, R; Hockings, H; Ledermann, J; Liberale, V; Lockley, M; Murali, K; Newton, C; Sarker, SJ; Shamash, J; Stoneham, S	1
Cai, S; Cai, Y; Cheng, X; Dai, Z; Jia, H; Jiang, R; Luan, Y; Pu, H; Shi, T; Tang, J; Tu, D; Tu, R; Wang, H; Yang, H; Zang, R; Zhang, Y	1
Khunnarong, J; Manusirivithaya, S; Pataradool, K; Pitakkarnkul, S; Prutthiphongsit, W; Srijaipracharoen, S; Tangjitgamol, S; Thavaramara, T	1
Badinloo, M; Esmaeili-Mahani, S	1
Chou, LC; Chung, CH; Huang, CH; Huang, LJ; Kuo, SC; Lee, FY; Lee, JC; Lien, JC; Way, TD; Wu, JC	1
Ajao, M; Snyder, P; Vachon, T	1
Curtin, J; Downey, A; Edwards, S; Kwa, M; Muggia, F; Reich, E; Wallach, R	1
Eungdamrong, J; McLellan, B	1
Billmire, DF; Cullen, JW; Davis, M; Egler, RA; Frazier, AL; Krailo, M; Malogolowkin, MH; Olson, TA; Pashankar, F; Rescorla, FJ; Rodriguez-Galindo, C; Schlatter, MG; Villaluna, D	1
Buist, MR; Kenter, GG; Sonke, GS; van der Velden, J; van Meurs, HS; Westermann, AM	1
Chen, X; Dai, H; Qian, Z; Wang, Y; Xu, X; Zhao, Y	1
Bahri, M; Ben Amar, M; Ben Salah, H; Daoud, J; Kallel, N; Lahmar, R	1
Kamura, T; Katsumata, N; Konishi, I; Matsumoto, K; Nakamura, K; Saitou, M; Satoh, T; Shibata, T; Takano, T; Yunokawa, M	1
Abonour, R; Einhorn, LH; Matei, D; Reddy Ammakkanavar, N	1
Chen, CA; Chou, CY; Chou, HH; Ho, CM; Huang, YF; Kang, CY; Lin, H; Lu, CH; Wen, KC; Weng, CS; Yu, MH	1
Brtnický, T; Fialová, A; Laštovička, J; Rob, L; Špíšek, R	1
Huang, L; Qian, Z; Qing, J; Wang, Y; Zhao, M; Zhou, F	1
Jaśkowski, P; Krzanowska, K; Krzanowski, M; Miarka, P; Sułowicz, W	1
Aoki, Y; Baba, T; Hatae, M; Kamura, T; Kasamatsu, T; Kikkawa, F; Kobayashi, H; Kodama, S; Ochiai, K; Saito, T; Sakuragi, N; Satoh, T; Sumi, T; Takano, M; Takeshima, N; Watanabe, Y; Yaegashi, N; Yokota, H; Yoshikawa, H	1
de Melo, AC; Lopes da Silva, J; Luiz Renna, N; Paulino, E	1
Kim, DY; Kim, JH; Kim, YM; Kim, YT; Nam, JH; Park, JY; Suh, DS	1
Carrillo, AM; Eischen, CM; Hicks, M; Khabele, D	1
Chaopotong, P; Jaishuen, A; Kuljarusnont, S; Leelapatanadit, C; Therasakvichya, S	1
Chang, TC; Chiang, YC; Hung, YC; Lai, HC; Lin, H; Liou, WS; Lu, CH; Sun, HD; Wang, KL; Wang, PH	1
Castex, MP; Faure-Conter, C; Fresneau, B; Kalfa, N; Martelli, H; Orbach, D; Patte, C; Verité, C	1
Altman, AD; Alwazzan, AB; Dean, E; Lotocki, R; Popowich, S; Robinson, C	1
Basu, B; Brenton, JD; Earl, HM; Gounaris, I; Hatcher, H; Iddawela, M; Parkinson, C; Pratt, J; Tan, LT	1
Aguiar, Sdos S; Almeida, MT; Barreto, JH; Bruniera, P; D'Andrea, ML; de Oliveira, CZ; Lima, ER; Lopes, LF; Lopes, PM; Macedo, CR; Martins, GE; Melaragno, R; Milone, M; Moreira, ME; Pianovski, MA; Sonaglio, V; Vianna, SM; Watanabe, FM	1
Chekerov, R; Ismaeel, F; Richter, R; Roots, I; Sehouli, J; Siepmann, T; Woopen, H	1
Hoskins, P; Kumar, A; Le, N; Santos, J	1
Baser, E; Cetinkaya, N; Gungor, T; Irkkan, C; Korkmaz, E; Yakut, HI	1
Wei, X; Yang, H; Yao, J; Yin, J	1
Hattori, Y; Hino, M; Kobayashi, Y; Kurahasi, T; Nakagawa, H; Wada, M	1
Fedorenko, A; Hayari, L; Sergio, S; Shir On, E; Solomonov, E; Zidan, J	1
Bunne, M; Fosså, SD; Gundersen, POM; Osnes, T; Skalleberg, J; Småstuen, MC; Solheim, O	1
Amatruda, JF; Billmire, DF; Cullen, JW; Dicken, BJ; Egler, RA; Frazier, AL; Krailo, M; Malogolowkin, MH; Olson, TA; Pashankar, F; Rescorla, FJ; Rodriguez-Galindo, C; Ross, JH; Schlatter, M; Shaikh, F; Villaluna, D	1
Errihani, H; Narimane, S	1
Hamasaki, A; Imazu, K; Kai, I; Kazusa, Y; Kodama, M; Kumagai, M; Kusumoto, S; Naito, H; Nakashima, Y; Ueda, K	1
Camara, O; Keil, E; Klare, P; Lichtenegger, W; Oskay-Oezcelik, G; Paulenz, A; Sehouli, J; Sommer, H; Stauch, M; Stengel, D; Zeimet, AG	1
Gao, J; He, Z; Li, X; Li, Y; Liu, M; Tang, H; Wang, Q; Zheng, J	1
Bae, DS; Choi, CH; Kang, H; Kim, BG; Kim, TJ; Kim, WY; Lee, JW	1
Castino, R; Démoz, M; Isidoro, C; Nicotra, G; Peracchio, C; Salini, A; Trincheri, NF; Valente, G	1
Benjapibal, M; Thanaboonyawat, I	1
Scorilas, A; Thomadaki, H	1
Hashimoto, M; Ishiyama, K; Nanjo, H; Sato, T; Sugawara, M; Yamamoto, Y	1
Levardon, M; Luton, D; Poujade, O; Pujade-Lauraine, E	1
Hirama, M; Isonishi, S; Kiyokawa, T; Kunito, S; Ochiai, K; Ogura, A; Suzuki, M; Tachibana, T; Tanaka, T	1
Chauhan, A; Dahiya, P; Gill, M; Singh, H; Verma, S	1
Berek, JS; Brady, M; Hutson, A; Markman, M	1
Ayan, I; Cicin, I; Eralp, Y; Guney, N; Kebudi, R; Saip, P; Topuz, E	1
Chekerov, R; Fotopoulou, C; Karavas, A; Lichtenegger, W; Sehouli, J; Trappe, R	1
Chang, FM; Cheng, YM; Chou, CY; Hsieh, TY	1
Castellino, SM; Hurt, G; Martinez-Borges, AR; Petty, JK; Press, JZ; Stribling, JT	1
Boivin, M; Lane, D; Piché, A; Rancourt, C	1
He, Y; Wu, WW; Wu, XL; Xu, L; Yang, KX; Yu, N	1
Bae, DS; Choi, CH; Kang, H; Kim, BG; Kim, TJ; Lee, JH; Lee, JW	1
Ast, A; Buhrmann, C; Du Bois, A; Glaser, F; Harter, P; Hirsch, T; Kasenda, B	1
Aplan, PD; Cheng, Y; Keenan, B; Nakahara, K; Roschke, AV; Zhang, Z	1
Leelahakorn, S; Manusirivithaya, S; Tangjitgamol, S; Thavaramara, T	1
Arai, K; Fukase, M; Ikarashi, H; Matsushita, H; Takayanagi, T	1
Bazin, IS; Fedyanin, MY; Garin, AM; Kanagavel, D; Narimanov, MN; Pokataev, IA; Tjulandin, SA; Tryakin, AA; Yakovleva, ES	1
Aydin, A; Balat, O; Cebesoy, FB; Ozturk, E; Sever, T; Ugur, MG	1
Bourdel, N; Canis, M; Gremeau, AS; Jardon, K; Kondo, W	1
Ferrandina, G; Gadducci, A; Lorusso, D; Mangili, G; Scarfone, G; Scibilia, G; Sigismondi, C; Tateo, S; Viganò, R; Villa, A	1
Ben-Shachar, I; Benshushan, A; Kogan, L; Lavie, M; Mejia-Gomez, J; Shushan, A	1
Brigulová, K; Cervinka, M; Sedláková, I; Tošner, J	1
Bell, MC; Muirhead, DM; Nelsen, LL	1
Clamp, AR; Evans, S; Griffiths, RW; Hasan, J; Jayson, GC; Kumaran, GC; Mitchell, CL; Welch, RS; Zee, YK	1
Chang, QY; Li, M; Li, XG; Li, YF; Liu, J; Song, PP; Tian, HM; Wang, XB; Wu, LY; Zhang, W; Zhao, D	1
Khunamornpong, S; Settakorn, J; Siriaunkgul, S; Sukpan, K; Suprasert, P	1
Fujimoto, T; Kumagai, S; Kurachi, H; Mizunuma, H; Nakahara, K; Nishiyama, H; Omi, H; Shoji, T; Sugiyama, T; Takano, T; Takatori, E; Tase, T; Yaegashi, N; Yokoyama, Y; Yoshizaki, A	1
Al-Barrak, J; Gilks, CB; Hoskins, P; Lau, H; Santos, JL; Swenerton, KD; Tinker, A	1
Alaggio, R; Bernini, G; Bisogno, G; Cecchetto, G; Collini, P; Conte, M; Cozza, R; Dall'igna, P; Ferrari, A; Terenziani, M; Virgone, C	1
Harada, T; Itamochi, H; Kigawa, J; Naniwa, J; Nonaka, M; Oishi, T; Sato, S; Shimada, M; Terakawa, N; Uegaki, K	1
Abdel-Hady Hemida, R; Abdel-Hady, el-S; El-Shamey, M; Gamal, A	1
Bruzzone, M; Centurioni, MG; Cosso, M; Cristoforoni, P; Ferrarini, M; Giannelli, F; Giglione, P; Gualco, M; Merlo, DF; Miglietta, L	1
Blagden, S; Gabra, H; Graham, J; Sharma, R	1
Hur, SY; Ki, EY; Lee, CW; Lee, KH; Lee, SJ; Park, JS; Park, ST; Ryu, KS; Song, MJ	1
Hwang, JH; Kang, S; Lim, MC; Park, SY; Seo, SS; Yoo, HJ	1
Jin, KL; Kim, DY; Kim, JH; Kim, KR; Kim, YM; Kim, YT; Nam, JH; Park, JY	1
Fukuda, H; Kamura, T; Katsumata, N; Konishi, I; Matsumoto, K; Saito, I; Shibata, T	1
Bernasconi, S; Bono, F; Broggini, M; Damia, G; Fruscio, R; Ganzinelli, M; Mangioni, C; Perego, P; Ricci, F; Russo, G; Signorelli, M	1
Bhattacharya, SK; Chatterjee, K; Mondal, S; Nath, SK	1
Bhat, RA; Chia, YN; Lim, YK; Yam, KL	1
Furuya, K; Goto, T; Kato, M; Kita, T; Kudoh, K; Miyamoto, M; Sasaki, N; Takano, M; Watanabe, A; Yoshikawa, T	1
Ktenidis, K; Papanikolaou, A; Pervana, S; Tsolakidis, D	1
Abe, K; Matsumura, Y; Mizunuma, H; Tamura, R; Taniguchi, R; Yanagita, T; Yokoyama, Y	1
Buyukberber, S; Elkiran, ET; Gumusay, O; Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M; Ozdemir, N; Ulas, A; Unal, O; Urakci, Z; Yaman, S	1
Douchi, T; Kamio, M; Matsuo, T; Terao, S; Tsuji, T; Yanazume, S	1
Kitao, A; Matsumoto, K	1
Ivanov, S	1
Cragg, MS; Erenpreisa, J; Huna, A; Inashkina, I; Ivanov, A; Jackson, TR; Jankevics, E; Kalnina, Z; Riekstina, U; Salmina, K; Townsend, PA	1
Choi, YJ; Chun, KY; Kim, YW; Ro, DY	1
Bunin, N; Stern, JW	1
Kamura, T; Ohta, S; Sugiyama, T; Tomonari, R	1
Matsui, H; Nagai, Y; Seki, K; Sekiya, S; Suzuka, K; Tanaka, N	1
Chew, DK; Domer, GS; Jaloudi, MA; Rogers, AM; Schutzer, RW	1
Iida, T; Kobayashi, T; Komiyama, S; Nakata, K; Shimizu, Y	1
Chuang, TC; Kao, MC; Law, SL; Lee, YJ; Li, JW; Lin, YS; Liu, JY; Wang, V	1
Alici, S; Aydiner, A; Eralp, Y; Saip, P; Topuz, E	1
Aida, K; Ayabe, T; Furuya, U; Hori, Y; Machida, R; Mori, H; Murase, T; Ohe, E; Shinozuka, N; Taguchi, A; Takeshita, S	1
Cady, J; de Gramont, A; Dehni, N; Fritel, X; Louvet, C; Milliez, J; Molitor, JL; Pigné, A; Sezeur, A; Tournigand, C	1
Bilgin, T; Filiz, G; Ozuysal, S	1
Ivanov, S; Zervoudis, S	1
Amsalem, H; Benshushan, A; Hiller, N; Nadjari, M; Prus, D	1
Al, A; Baykal, C; Dölen, I; Kose, MF; Ozer, S; Tulunay, G	1
Ali, K; Fung, MF; Hopkins, L; Le, T; Leis, A; Pahwa, P; Reeder, B; Wright, K	1
Billmire, D; Cushing, B; Davis, M; Giller, R; Lauer, S; London, W; Olson, T; Rescorla, F; Schlatter, M; Vinocur, C	1
Ikeba, K; Kinoshita, K; Maeda, H; Okubo, M; Takeda, S	1
Rana, S; Warren, BK; Yamada, SD	1
Einhorn, LH; Look, KY; McClean, JW; Shaheen, M; Stender, MJ	1
Esfahani, JK; Gilani, MM; Moosavi, AS; Tehranian, A	1
Billmire, DF; Castleberry, RP; Colombani, P; Cullen, JW; Cushing, B; Davis, MM; Giller, R; Hawkins, EP; Lauer, SJ; London, WB; Marina, NM; Olson, TA; Perlman, EJ; Rescorla, F; Rogers, PC; Vinocur, CD	1
Kishida, T; Komiyama, M; Mori, T; Noguchi, M; Noguchi, Y; Ohnishi, M; Sawaguchi, K; Yabushita, H	1
Billmire, DF; Cullen, JW; Cushing, B; Davis, MM; Giller, RH; Lauer, SJ; London, WB; Marina, N; Olson, TA; Rescorla, F; Rogers, PC	1
Buller, RE; Geisler, JP; Lush, R; Sanders, L; Shahin, MS; Sood, AK; Sorosky, JI; Sullivan, D	1
Hatae, M; Nakamura, T; Onishi, Y	1
Herzog, TJ	1
Aghajanian, C; Armstrong, DK; Burnett, AF; Kauderer, J; Lentz, SS; Williams, SD	1
Aravantinos, G; Bamias, A; Dimopoulos, MA; Efstathiou, E; Gika, D; Hamilos, G; Kalofonos, H; Kouroussis, C; Papadimitriou, C; Rodolakis, A; Skarlos, D; Vlahos, G	1
Sugiyama, T	1
Engelholm, SA; Gronlund, B; Horvath, G; Mäenpää, J; Ridderheim, M	1
Baur, M; Dittrich, Ch; Gneist, M; Hudec, M; Schernhammer, E; Sevelda, P; Speiser, P	1
Azevedo, CH; Carvalho, JP; Maranhão, RC; Valduga, CJ	1
Castine, M; Greco, FA; Hainsworth, JD; Kalman, L; Sylvester, L	1
Ariyoshi, Y; Fukuoka, M; Furuse, K; Hatae, M; Hirabayashi, K; Noda, K; Ogawa, M; Takaku, F; Yakushiji, M	1
Brown, J; Burke, TW; Deavers, MT; Gershenson, DM; Munsell, MF; Ramondetta, LM; Shvartsman, HS	1
Bakalarz, R; Banasik, A; Góźdź, S; Lankoff, A; Lesisz, D; Lisowska, H; Padjas, A; Wojcik, A	1
Braybrooke, JP; Davies, SL; Echeta, C; Flanagan, E; Ganesan, TS; Hickson, ID; Joel, S; Levitt, NC; Madhusudan, S; Propper, DJ; Te Poele, R	1
Aoki, Y; Higashino, M; Ishii, S; Tanaka, K	1
Chin, WW; Dantzig, AH; Iversen, PW; Jin, S; Krishnan, V; Lesoon, A; Moore, RE; O'Brien, KA; Peek, VL; Perry, WL; Rolfe, M; Sampath, J; Shepard, RL; Shyjan, A; Tighe, M; Williamson, M; Yaden, B	1
Binaschi, M; Camarda, G; Goso, C; Maggi, CA; Manzini, S; Salvatore, C	1
Collette, L; de Mulder, PH; de Prijck, L; de Wit, R; Fosså, SD; Horwich, A; Kaiser, G; Koriakine, O; Paluchowska, B; van Oosterom, AT	1
Bell, JG; Fusco, NL; Markman, M; Rose, PG	1
Balan, KV; Dimas, K; Han, Z; Pantazis, P; Sitaras, NM; Wyche, JH	1
Bayless, KJ; Davis, GE; Mavila, A; Maxwell, SA; Rivera, A	1
Cheng, JQ; He, L; Kruk, P; Nicosia, SV; Yang, H	1
Berdel, WE; Frickhofen, N; Haas, R; Heimpel, H; Hinke, A; Hossfeld, DK; Kreienberg, R; Kuhn, W; Möbus, V; Opri, F; Sandherr, M; Schneeweiss, A; Thomssen, C	1
Huang, ZH; Ling, JY; Sun, XF; Xia, Y; Yang, QY; Zhen, ZJ	1
Boudrias, M; Fortin, D; Garant, MP; Gendron, C	1
Bieth, E; Brennetot, C; Hofman, P; Pedeutour, F; Rouzier, C; Soler, C	1
Brainard, J; McBee, WC; Rose, PG; Sawady, J	1
Li, J; Wu, X; Yang, W	1
Kamura, T; Kitagawa, R; Nishio, S; Shouji, T; Sugiyama, T; Ushijima, K; Yoshizaki, A	1
Bookman, MA	2
Behtash, N; Karimi Zarchi, M; Modares Gilani, M	1
Artac, H; Caliskan, U; Ilerisoy-Yakut, Z; Koksal, Y; Reisli, I; Ucar, C; Yurtcu, M	1
Heath, J; Kanwar, VS; Krasner, CN; Pearce, JM	1
Aydin, Y; Cicin, I; Eralp, Y; Ozluk, Y; Saip, P; Selam, M; Topuz, E; Topuz, S	1
Lehoczky, O; Pulay, T	1
Culine, S; de La Motte Rouge, T; Duvillard, P; Haie-Meder, C; Kerbrat, P; Lhommé, C; Morice, P; Pautier, P; Rey, A; Troalen, F	1
de Vries, EG; De Vries-Hospers, HG; Holthuis, JJ; Mulder, NH; Postmus, PE; Sibinga, CT; Sleijfer, DT; van Imhoff, GW; Vriesendorp, R	1
Adolphs, HD; Hartlapp, J; Schwabe, HW	1
Corden, BJ; Jacob, J; Ostchega, Y; Ozols, RF; Wesley, MN; Young, RC	1
Bagshawe, KD	1
Coombs, A; Hanson, J; Moore, JL	1
Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, R; Ryssel, HJ; Sonntag, RW	1
Jungi, WF	1
Płuzańska, A; Robak, T	1
Aalders, JG; Bouma, J; Mulder, NH; Postmus, PE; Sleijfer, DT; Vriesendorp, R; Willemse, PH	1
Hillcoat, BL	1
Clarke-Pearson, DL; Creasman, WT; Smith, EB	1
Ball, H; Blessing, JA; Hanjani, P; Liao, SY; Williams, S	1
Cortés-Funes, H; Díaz-Puente, MT; García-Prats, MD; Lianes, P; López Martín, E; López-Brea, M; Mayordomo, JI; Mendiola, C; Paz-Ares, L; Rivera, F	1
Bosl, GJ; Motzer, RJ; Parker, RJ; Perera, F; Poirier, MC; Reed, E; Shamkhani, H; Tang, D; Tsai, WY	1
Bender, JG; Coon, J; George, S; Ghalie, R; Kaizer, H; Lee, W; Lum, L; McLeod, B; Unverzagt, KL; Van Epps, D	1
Castaigne, D; Culine, S; Droz, JP; Duvillard, P; Kattan, J; Leclere, J; Lhomme, C; Michel, G; Pico, J	1
Advani, SH; Gopal, R; Kurkure, PA; Nair, CN; Nair, R; Pai, SK; Saikia, TK; Sampat, MS	1
Castracane, VD; Hamous, J; MacLaughlin, DT; Morrow, MS; Puls, LE; Schneyer, A	1
Aluigi, MG; Cimoli, G; De Sessa, F; Mazzoni, A; Noviello, E; Parodi, S; Rovini, E; Russo, P	1
Gershenson, DM	1
Gabizon, AA; Gorodetsky, R; Mou, X; Vexler, AM	1
Chiba, T; Fujioka, T; Hiura, M; Murakami, J; Nogawa, T; Shigemasa, K; Shimokawa, T; Yokoyama, T	1
von Eyben, FE	1
Fichtner, I; Goan, SR; Herrmann, F; Just, U; Karawajew, L; Krause, KP; Schultze, W; von Harsdorf, S; von Schilling, C	1
Dunn, J; Earl, HM; Kerr, DJ; Liu, B; Poole, CJ	1
Hayakawa, S; Sato, S; Yajima, A	1
Fujimoto, A; Ishihara, O; Itoyama, S; Kinoshita, K; Saitou, M; Takeda, S	1
Advani, SH; Desai, PB; Kapoor, G; Kurkure, PA; Nair, CN; Nair, R; Pai, K; Saikia, TK; Vege, D	1
Ayash, LJ; Elias, AD; Frei, E; Gonin, R; Mazanet, R; McCauley, M; Schnipper, L; Schwartz, G; Tepler, I; Wheeler, C	1
Boonstra, H; de Jong, RS; de Vries, EG; Mulder, NH; Sleijfer, DT; van der Graaf, WT; van der Zee, AG; Willemse, PH	1
de Araujo, RA; de Camargo, B; Dondonis, M; Lopes, LF; Morinaka, E	1
Blake, KI; Gerrard, MP	1
Cimoli, G; De Sessa, F; Mazzoni, A; Noviello, E; Parodi, S; Rovini, E; Russo, P; Valenti, M	1
Higashide, K; Kikkawa, F; Maeda, O; Misawa, T; Obata, NH; Suganuma, N; Tomoda, Y	1
Cooper, MA; Einhorn, LH	1
Ben-Baruch, G; Brenner, H; Menczer, J; Rizel, S	2
Heinonen, E; Hinkka, SM; Karnani, P; Klemi, PJ; Korpijaakko, TA; Kuoppala, TA; Lähde, MA; Laine, AM; Mäenpää, JU; Nuoranne, EK	1
Göbel, U; Harms, D; Pape, H; Spaar, HJ; Wessalowski, R; Willers, R	1
Helmer, H; Kurz, C; Obermair, A; Pehamberger, K; Sevelda, P; Vavra, N	1
Comella, G; Comella, P; Conforti, S; Frasci, G; Mastrantonio, P; Persico, G; Zullo, F	1
Neijt, JP	1
André, T; Bonnak, H; Bouleuc, C; Donsimoni, R; Esteso, A; Firmin, C; Gerota, J; Izrael, V; Lotz, JP; Merad, Z	1
Ballester, OF; Cooper, BW; Creger, RJ; Elfenbein, GJ; Fields, KK; Hiemenz, JH; Janssen, WE; Lazarus, HM; Perkins, JB; Zorsky, PE	1
Braly, PD; Howell, SB; Kim, S; Kirmani, S; McClay, EF; McClay, ME; Plaxe, SC; Wilgus, L	2
Hill, BT; Hurst, HC; McClean, S; Whelan, RD	1
Funayama, Y; Kubota, N; Kunikane, H; Nishio, K; Ogasawara, H; Ohira, T; Ohmori, T; Saijo, N; Takeda, Y; Terashima, Y	1
Hondoh, T; Kimura, T; Mitsuya, T; Miyakawa, Z; Moriyama, S; Notake, Y; Shimizu, A; Watanabe, S; Yoshida, K	1
de Wit, R; Logmans, A; Stoter, G; van den Gaast, A; van der Burg, ME; Verweij, J	1
Adler, SS; Feingold, JM; Ghalie, R; Kaizer, H; Korenblit, AD; Manson, S; Pruett, J; Reynolds, J; Valentino, LA	1
Cimoli, G; Conte, P; De Sessa, F; Mazzoni, A; Parodi, S; Russo, P; Valenti, M	1
Carstensen, J; Malmström, H; Simonsen, E	1
Fanning, J; Hilgers, RD; Hutson, E	1
Aggarwal, S; Fisk, B; Glisson, BS; Ioannides, CG; O'Brian, CA; Restifo, N; Wharton, JT	1
Eguchi, K; Kanzawa, F; Karato, A; Kubota, N; Nishio, K; Ohe, Y; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T	1
Braly, PS; Cates, C; Howell, SB; Kim, S; Kirmani, S; McClay, EF; Plaxe, SC; Saltzstein, SL	1
Clynes, M; Moran, E; Redmond, A	1
Cook, J; Fisher, J; Goldspiel, B; Hahn, SM; Kaufman, D; Liebmann, JE; Mitchell, JB; Venzon, D	1
Cimoli, G; De Sessa, F; Parodi, S; Russo, P; Valenti, M	1
Abe, H; Takushima, Y; Yamashita, S	1
Greco, FA	1
Beddoe, AM; Cohen, CJ; Dottino, PR	1
Bourhis, JH; Castagna, L; Chazard, M; Droz, JP; Ibrahim, A; Maraninchi, D; Pico, JL	1
Barrada, M; Baur, M; Dittrich, C; Fazeny, B; Hudec, M; Salzer, H; Sevelda, P; Vavra, N	1
Hoskins, PJ; Swenerton, KD	1
Edmonds, PM; Evans, TR; Gallagher, CJ; Gore, ME; Harper, PG; Mansi, JL; Seymour, MT; Slevin, ML	1
Demukai, H; Hirashima, Y; Kobayashi, T; Kubota, T; Shimura, T; Suzuki, A; Tanaka, Y	1
Cavalli, F; Colombo, N; D'Incalci, M; Mangioni, C; Marzola, M; Pagani, O; Sessa, C; Zucchetti, M	1
Blessing, JA; Major, F; Manetta, A; Markman, M	1
Chen, SC; Curtin, J; Groshen, S; Jeffers, S; Morrow, CP; Muggia, FM; Russell, C; Schlaerth, J	1
Bosl, GJ; Gulati, SC; Lin, S; Lyn, P; Mazumdar, M; Menendez-Botet, C; Motzer, RJ; Tong, WP; Vlamis, V	1
Alcaraz, J; Andrews, P; Braly, P; Goel, R; Gorelick, S; Hoff, S; Kim, S; Kirmani, S; McClay, EF; Plaxe, S	1
Adachi, S; Imamura, K; Ito, K; Kiyozuka, Y; Murakami, F; Nishimura, H; Noda, T; Shintani, M; Tamori, N; Yakushiji, M	1
Baker, TR; Hempling, RE; Piver, MS	1
Ciavattini, A; Cignitti, M; De Nictolis, M; Garzetti, GG; Goteri, G; Romanini, C; Tranquilli, AL	1
Malmström, H; Rasmussen, S; Simonsen, E	1
Abfalter, E; Dapunt, O; Hetzel, H; Koza, A; Marth, C; Pointner, E; Windbichler, G; Zeimet, AG	1
Cimoli, G; Conte, P; Mariani, GL; Parodi, S; Russo, P; Valenti, M; Venturini, M	1
Burke, TW; Gershenson, DM; Levenback, C; Matthews, CM; Morris, M; Wharton, JT	1
Fujiwara, K; Kohno, I; Ohishi, Y	1
Smith, CD; Zhang, X	1
Kato, J; Yasumizu, T	1
Carcangiu, ML; Cass, I; Chambers, JT; Chambers, SK; Kohorn, EI; Resnik, E; Schwartz, PE	1
Dose, J; Freitag, K; Graeff, H; Jänicke, F; Kuhn, W; Pache, L; Schmalfeldt, B; Ulm, K	1
Balmanno, K; Chapman, F; Charlton, CJ; Gumbrell, L; Igwemezie, LN; Lind, MJ; Millward, MJ; Mummaneni, V; Newell, DR; Proctor, M	1
Delva, R; Gamelin, E; Guérin, O; Larra, F; Lortholary, A; Maillart, P; Mege, M; Pein, F	1
Cain, JM; Collins, C; Figge, DC; Greer, BE; Livingston, RB; Petersdorf, S; Tamimi, HK	1
Hasumi, K; Shimizu, Y; Umezawa, S	1
Chauvergne, J; Chinet-Charrot, P; Stöckle, E; Thomas, L; Toulouse, C	1
Harstrick, A; Klaassen, U; Schleucher, N; Schröder, J; Seeber, S; Vanhoefer, U; Wilke, H	1
Gabriele, A; Mangioni, C; Miceli, D; Monico, SL; Zanetta, G	1
Bower, M; Fife, K; Holden, L; Newlands, ES; Paradinas, FJ; Rustin, GJ	1
Xu, J; Zhang, X; Zhu, H	1
Anteby, SO; Edelman, DZ; Peretz, T	1
Clynes, M; Dolan, E; Heenan, M; Kavanagh, K; Maher, M; Moriarty, M; O'Neill, P; Redmond, A	1
Ahn, C; Doroshow, JH; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Raschko, J; Shibata, S; Somlo, G; Tetef, M	1
Barbo, DM; Baurick, K; Black, W; Kammerer-Doak, D; Smith, HO	1
Chen, Z; Mashima, T; Naito, M; Tsuruo, T	1
Basu, A; Saijo, N; Weixel, K	1
Arai, Y; Inoue, K; Kubo, T; Nishida, M; Sasaki, J; Sato, Y	1
Hasegawa, G; Hori, H; Kato, N; Kazeto, H; Kobayashi, I; Tsukahara, Y; Yamahara, N; Yamamuro, O	1
Cannistra, SA; Korsmeyer, S; Strobel, T; Swanson, L	1
Fanning, J; Hilgers, RD	1
Hoskins, PJ; Lee, N; McMurtrie, EM; Pike, JA; Swenerton, KD	1
Fennelly, D; Gogas, H	1
Kanazawa, K; Moromizato, H	1
Bachier, C; Bird, RE; Chang, A; Cheng, S; Claxton, D; Cote, R; Deisseroth, AB; Ellerson, D; Fu, SQ; Giles, RE; Hanania, EG; Hester, J; Holmes, F; Holzmayer, T; Hortobagyi, G; Kavanagh, J; Korbling, M; Kudelka, A; Ostrove, JM; Rahman, Z; Seong, D; Su, Y; Thall, P; Wang, T; Zu, Z	1
Bliss, J; Horwich, A	1
Beesley, JS; Hamilton, TC; Johnson, SW; Laub, PB; Ozols, RF	1
Deppe, G; Tomlinson, MW; Treadwell, MC	1
Benedetti Panici, P; Caracussi, U; Foddai, ML; Leone, G; Mancuso, S; Maneschi, F; Menichella, G; Pierelli, L; Salerno, MG; Scambia, G; Serafini, R; Vittori, M	1
Fleming, GF; Langhauser, C; Rotmensch, J; Skoog, LA; Waggoner, SE	1
Barakat, RR; Brown, C; Curtin, JP; Fennelly, D; Pizzuto, F; Venkatraman, ES	1
Blaauwgeers, JL; de Blok, S; Swartjes, JM	1
Fryer, CJ; Lawlor, ER; Murphy, JI; Sorensen, PH	1
Boonstra, H; de Bruijn, HW; de Jong, RS; de Vries, EG; Hofstra, LS; Mulder, NH; Willemse, PH	1
Ikeba, K; Ishihara, O; Kinoshita, K; Okubo, T; Seki, H; Takagi, Y; Takeda, S	1
Berman, ML; Brewer, C; Cappuccini, F; Macri, C; Rogers, LW; Tewari, K	1
Ozols, RF	2
Culine, S; Droz, JP; Lhommé, C	1
Blessing, JA; Homesley, HD; Mayer, AR; Rose, PG	1
Cheng, X; Itamochi, H; Kanamori, Y; Kigawa, J; Minagawa, Y; Oishi, T; Okada, M; Terakawa, N	1
Advani, SH; Chougule, A; Gladstone, B; Kadam, PR; Kapoor, G	1
Burger, CW; Hoekman, K; van Rijswijk, RE; Verheijen, RH; Vermorken, JB	1
Confer, DL; Epstein, RB; Mandanas, RA; Saez, RA; Selby, GB	1
Aghajanian, C; Almadrones, L; Barakat, RR; Brown, C; Curtin, JP; Shapiro, F; Spriggs, D; Venkatraman, ES	1
Cusidó, MT; García, A; Gonzalez, J; Jordá, B; Xercavins, J	1
Fujimori, R; Sanada, H; Sekine, M; Serikawa, T; Shichiri, K; Tanaka, K	1
El-Deiry, WS; Peters, C; Saftig, P; Wu, GS	1
Canzler, E; Graeff, H; Janicke, F; Kroner, M; Kuhn, W; Nöschel, H; Pache, L; Renziehausen, K; Richter, B; Schmalfeldt, B; Späthe, K; Tilch, G; Ulm, K	1
Egorova, NI; Garin, AM; Gorozhanskaia, EG; Koroleva, EIu; Kushlinskiĭ, NE; Larionova, VB	1
Anagnostopoulos, A; Andreopoulou, E; Aravantinos, G; Aspropotamitis, A; Dimopoulos, MA; Fountzilas, G; Michalas, S; Papadimitriou, C; Papadopoulou, M; Pavlidis, N; Pectacides, D	1
Iwasaki, M; Kudo, R; Mizumoto, H; Sagae, S; Terasawa, K	1
Matsumoto, K; Mishima, M; Nakagawa, S; Onda, T; Taketani, Y; Yamada, M; Yasugi, T; Yoshikawa, H	1
Fujii, S; Hasegawa, K; Hirabayasi, K; Ikeda, M; Izumi, R; Kono, I; Kudo, R; Niitani, H; Nishiya, I; Noda, K; Ochiai, K; Ogita, Y; Okada, H; Ozaki, M; Saito, T; Sugimori, H; Suzuoki, Y; Tanaka, K; Terashima, Y; Tomoda, Y; Umesaki, N; Yajima, A; Yakushiji, M; Yamabe, T; Yamamoto, T	1
Guechev, A; Loves, WJ; Peters, GJ; Pinedo, HM; Postmus, PE; Smid, K; van Moorsel, CJ; Veerman, G; Vermorken, JB	1
Colombo, N; Franchi, D; Parma, G	1
Bundy, BN; Homesley, HD; Hurteau, JA; Roth, LM	1
Aoki, Y; Kase, H; Kodama, S; Kurata, H; Tanaka, K	1
Oliver, RT	1
Arand, M; Becker, R; Dornhöfer, N; Hengstler, JG; Kett, A; Knapstein, PG; Lange, J; Meinert, R; Oesch, F; Tanner, B	1
Akutsu, M; Kano, Y; Mori, K; Suzuki, K; Tsunoda, S; Yazawa, Y	1
Endoh, T; Fujiwara, O; Hasegawa, J; Kimura, T; Narabayashi, A; Notake, Y; Okuyama, D; Ookubo, K; Shimizu, A; Takahashi, J; Yoda, A	1
Brewer, M; Gershenson, DM; Herzog, CE; Mitchell, MF; Silva, EG; Wharton, JT	1
Boldogh, I; Denning, T; Horton, JK; Mitra, S; Roy, G; Roy, R	1
Hong, W; Liu, L; Zhang, R	1
Hasegawa, K; Ichimura, T; Nishimura, R; Takemori, M	1
Berkowitz, R; Cannistra, SA; Kim, Y; Matulonis, U; Niloff, J; Quartulli, M; Seiden, M; Tung, N	1
Bilgrami, S; Bona, RD; Edwards, RL; Feingold, JM; Kapur, D; Khan, AM; Rodriguez-Pinero, F; Tutschka, PJ	1
Aleman, A; Anderlini, P; Bast, RC; Bevers, M; Bodurka-Bevers, D; Boyer, J; Burke, T; Champlin, RE; Donato, ML; Freedman, R; Gajewski, JG; Gershenson, D; Giralt, S; Ippoliti, C; Korbling, M; Lauppe, J; Levenback, C; Molldrem, J; Ueno, N; Wharton, JT; Wolf, J	1
Kanazawa, K; Sakumoto, K; Suzuki, T	1
Johnson, LM; Lorico, A; Murren, JR; Rappa, G; Sartorelli, AC	1
Aravantinos, G; Bafaloukos, D; Dimopoulos, MA; Kiamouris, C; Kosmidis, P; Papadimitriou, C; Papakostas, P; Pavlidis, N; Sikiotis, K; Skarlos, DV	1
Bardou, VJ; Bertucci, F; Delpero, JR; Faucher, C; Houvenaeghel, G; Maraninchi, D; Viens, P	1
Chan, LY; Wong, SF; Yu, VS	1
Malhotra, N; Sood, M	1
Adwankar, MK; Juvekar, AS; Tongaonkar, HB	1
Fowler, JM; Greer, BE; Horowitz, IR; McGuire, WP; Rodriguez, M; Rose, PG; Waggoner, S	1
Bodurka-Bevers, D; Champlin, RE; Donato, ML; Gershenson, D; Wharton, JT	1
Kisic, J; Tropé, CG; Vergote, I	1
Ohara, N; Teramoto, K	1
Hamazaki, M; Honzumi, M; Inaba, H; Ito, M; Kawasaki, H; Komada, Y; Okugawa, T; Sakurai, M; Toyoda, N; Uchida, K	1
Fujita, T; Hayashi, T; Higashihara, J; Irie, T; Ohishi, Y; Shigematsu, T	1
Bailey, S; Gornall, P; Gray, E; Hale, J; Imeson, J; Mann, JR; McKeever, P; Oakhill, A; Raafat, F; Robinson, K; Sokal, M	1
Lambrou, N; Trimble, EL	1
Goker, E; Karabulut, B; Omay, SB; Sanli, UA; Sezgin, C; Terzioglu, E; Uslu, R	1
Baker, SD; Fleming, GF; Fracasso, PM; Look, KY; McGuire, WP; Muggia, FM; Roth, BJ; Sutton, GP	1
Abou-Loz, SK; El-Lamie, IK; El-Lamie, KI; Shehata, NA	1
Fanucchi, MP; Giblin, J; McGuire, WP	1
Malik, IA	1
Cabeza, R; Hindenburg, A; Jeyakumar, A	1
Kao, GD; McKenna, WG; Yen, TJ	1
Ferrandina, G; Greggi, S; Leone, G; Mancuso, S; Menichella, G; Pierelli, L; Salerno, MG; Scambia, G	1
Brugarolas, A; García-Rayo, S; Inogés, S; Martín-Algarra, S; Martínez-Aguillo, M; Ordóñez, JM; Pérez-Calvo, J; Ramón y Cajal, T; Santisteban, M; Subirá, ML	1
Iwahashi, K; Kitaoka, Y; Sakurai, N; Shiraishi, S; Tanaka, Y	1
Hirose, T; Komiyama, S; Komuro, Y; Kurahashi, T; Mikami, M; Sakaiya, N; Tei, C	1
Cady, J; de Gramont, A; Dehni, N; Lejeune, V; Louvet, C; Marpeau, L; Molitor, JL; Pigne, A; Sezeur, A; Tournigand, C	1
du Bois, A	1
Guidos, BJ; Selvaggi, SM	1
Li, X; Liu, L; Wu, L	1
Alvarnas, J; Chow, W; Doroshow, JH; Forman, S; Hamasaki, V; Leong, L; Longmate, J; Margolin, K; McGonigle, K; McNamara, M; Morgan, RJ; Raschko, J; Schriber, J; Shibata, S; Somlo, G; Vasilev, S; Yen, Y	1
Ding, Z; Wu, GS	1
de Wit, R; Hilkens, PH; van den Bent, MJ; van der Burg, ME; van Putten, WL	1
Thigpen, T	1
Mahmoudi, M; Meyer, T; Nelstrop, AE; Rustin, GJ	1
Clamp, A; Jayson, GC	1
de Wit, R; Kruit, WH; Logmans, A; Stoter, G; van der Burg, ME; van Putten, WL; Verweij, J	1
Aiba, K; Akaza, H; Blackledge, G; Boku, N; Ikeda, T; Isonishi, S; Kato, M; Kawai, K; Mikami, O; Ohashi, Y; Saeki, T; Saijo, N; Sone, S; Stribling, D; Tsukagoshi, S; Tsuruo, T	1
Bergauer, F; Dimpfl, T; Janni, W; Kaestner, R; Linka, F; Rack, B; Rjosk, D; Schindlbeck, C; Sommer, H; Strobl, B	1
Fusco, N; Greer, B; McGuire, W; Rodriguez, M; Rose, PG; Walker, J	1
Hensley, ML	1
Akeshima, R; Iba, T; Itamochi, H; Kamazawa, S; Kanamori, Y; Kigawa, J; Sultana, H; Terakawa, N	1
Beckmann, C; Flury, R; Frei, P; Holdener, E; Jungi, WF; Senn, HJ	1
Bagshawe, KD; Begent, RH; Newlands, ES; Rustin, GJ	1
Decker, DG; Edmonson, JH; Jorgensen, EO; Malkasian, GD; Webb, MJ	1
Edmonson, JH	1
D'Incalci, M; Erba, E; Lorico, A; Sen, S	1
Lafleur, MV; Lankelma, J; Mans, DR; Pinedo, HM; Retèl, J; Schuurhuis, GJ; Treskes, M	1
Cimoli, G; Conte, P; Conzi, G; Noviello, E; Orengo, G; Pagnan, G; Parodi, S; Russo, P; Schenone, F; Venturini, M	1
Abfalter, E; Dapunt, O; Marth, C; Thaler, J; Zeimet, AG	1
Abel, G; Kelland, LR	1
Kudo, R; Sagae, S	1
Alonso, C; Climent, MA; Germá, JR; Izquierdo, MA; Ojeda, B; Seguí, MA	1
Chambers, JT; Chambers, SK; Kohorn, E; McIntosh, S; Schwartz, PE	1
Buettner, R; Hofstaedter, F; Knuechel, R; Le-Ruppert, K; Masters, JR; Seegers, S; Tainsky, MA	1
Hatae, M; Hokanishi, H; Kume, H; Maeda, Y; Nakagawa, S; Onishi, Y	1
Almadrones, L; Barakat, R; Curtin, J; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S	4
Hansen, HH; Hansen, M; Hansen, OP; Lund, B	1
Dempke, WC; Hill, BT; Whelan, RD	1
Fujimoto, R; Kumagai, K; Okamura, S; Sugimoto, O; Takahara, T; Ueki, K; Ueki, M; Yamada, T; Yanagawa, Y	1
Funatsu, M; Hada, Y; Kimura, T; Miyakawa, Z; Notake, Y; Shimizu, A; Taguchi, A; Tamura, K	1
Hasegawa, E; Hirakawa, S; Momose, K; Ohmura, G; Watanabe, H	1
Boonstra, H; Bouma, J; de Vries, EG; Mulder, NH; Sleijfer, DT; Willemse, PH	1
Hayward, IP; Hurst, T; Khoo, SK; Parsons, PG	1
Baiocchi, G; Benedetti Panici, P; Foddai, ML; Greggi, S; Menichella, G; Paoloni, A; Pierelli, L; Scambia, G; Serafini, R; Vittori, M	1
Cangir, A; Edwards, CL; Gershenson, DM; Kavanagh, JJ; Morris, M; Silva, EG; Stringer, CA; Wharton, JT	1
Biddle, WC; Crickard, K; Crickard, U; Fanning, J; Foon, KA; Goldrosen, M; Piver, MS	1
Daugaard, G; Hansen, HH; Rørth, M	1
Ehsan, MN; Lau, DH; Lewis, AD; Sikic, BI	1
Blessing, JA; Hatch, KD; Homesley, HD; Williams, SD	1
Akamatsu, K; Endo, K; Kaiho, S; Koizumi, K; Koizumi, M; Matsumoto, T; Mitsui, H; Morikawa, K; Tsunenari, T	1
Bottero, G; Bruzzone, M; Campora, E; Donadio, M; Ferrari, I; Giudici, S; Iskra, L; Merlini, L; Ragni, N	1
Araki, H; Funatsu, M; Hada, Y; Kimura, T; Notake, Y; Shimizu, A	1
Itoyama, Y; Kitano, I; Kochi, M; Korematsu, K; Kuratsu, J; Seto, H; Uemura, S; Ushio, Y	1
Andriessen, MP; Mulder, JG; Sleijfer, DT	1
Almadrones, L; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S	1
Bolis, G; Borello, C; Maggi, R; Presti, M; Scarfone, G; Zanaboni, F	1
Hayashi, K; Ito, T; Sugino, N; Yakabe, A; Yamashita, S	1
Muggia, FM; Russell, CA	1
Achterrath, W; Eiermann, W; Hepp, H; Lenaz, L	1
Braly, P; Howell, SB; Kim, S; Kirmani, S; McClay, EF; Plaxe, S	1
Comis, RL; Hogan, M; LaCreta, F; O'Dwyer, JL; O'Dwyer, PJ; Rosenblum, N	1
Arakawa, A; Kato, N; Suzumori, K; Yagami, Y; Yasui, Y	1
Goel, R; Howell, SB; Kim, S; Kirmani, S; Lucas, WE; McVey, L; Morris, J	1
Azab, M; Baume, D; Beaujean, F; Droz, JP; Ghosn, M; Gilles, E; Gouyette, A; Ostronoff, M; Pico, JL; Salloum, E	1
Chasen, MR; Falkson, G; Falkson, HC	1
Andrews, PA; Howell, SB; Katz, EJ; Kling, KM; Vick, JS	1
Hamaguchi, K; Harataka, J; Nagasue, N; Nishimura, H; Okura, N; Yakushiji, M	1
Eckhardt, S; Hernádi, Z; Kerpel-Fronius, S; Mechl, Z; Pawlicki, M; Sopkova, B; Telekes, A; Thurzó, L	1
Hirabayashi, K	1
Ishihara, H; Kanamori, Y; Kigawa, J; Matsui, K; Minagawa, Y; Morishita, K	1
Fujita, H; Ito, R; Okada, H; Yamamoto, T	1
Kinoshita, K; Kojima, T; Sakamoto, S; Takada, S; Takeda, S	2
Csaba, I; Garadnay, B; Göcze, P; Keller, G; Krommer, K	1
Goel, R; Horton, MC; Howell, SB; Kim, S; Kirmani, S; Lucas, WE; McVey, L; Morris, J; Weiss, RJ; Zimm, S	1
Hansen, F; Krog, H; Malthe, I	1
Kaern, J; Tropé, C; Vergote, I; Vossli, S	1
Adachi, S; Hirooka, C; Ichijo, M; Kiyozuka, Y; Noda, T; Oku, M; Yamamoto, T	1
Bielat, K; Castillo, NB; Lele, SB; Patsner, B; Piver, MS; Tsukada, Y	1
Pinkerton, CR; Pritchard, J; Spitz, L	1
Choo, YC; Ma, HK; Wong, LC	1
Gershenson, DM; Kavanagh, JJ; Kline, RC; Larson, DM; Rutledge, FN; Wharton, JT	1
Auman, J; Bosl, GJ; Carey, R; Chan, E; Geller, NL; Herr, H; Morse, M; Sogani, P; Vogelzang, NJ; Whitmore, WF	1
Bagshawe, KD; Begent, RH; Newlands, ES; Pektasides, D; Rustin, GJ	2
Peckham, MJ; Smales, E	1
Herbst, AL; Senekjian, EK; Talerman, A; Weiser, PA	1
Hughes, CS; Shen, JW; Subjeck, JR	1
Goel, R; Howell, SB; Kirmani, S	1
Akard, L; Goulet, R; Hoffman, R; Loehrer, PJ; Nichols, CR; Roth, BJ; Tricot, G; van Besien, K; Williams, SD; Wolff, SN	1
Jimi, S; Kurano, A; Maeda, K; Mashiba, H; Okadome, M; Shigematsu, T; Shimamoto, T; Ushijima, H; Watanabe, Y	1
Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S	1
Chang, A; Cheung, TH; Shiu, W; Wong, WS	1
Aalders, JG; de Vries, EG; Mulder, NH; Mulder, PO; Sibinga, CT; Sleijfer, DT; Willemse, PH	1
Almadrones, L; Chapman, D; Hakes, T; Hoskins, W; Jones, W; Markman, M; Ochoa, M; Reichman, B; Rubin, S; Saigo, P	1
Abramson, IS; Hom, D; Howell, SB; Sanga, R; Vick, JS	1
Athanassiou, AE; Bafaloukos, D; Barbounis, V; Dimitriadis, M; Pectasides, D; Varthalitis, I	1
Bénard, J; Da Silva, J; Riou, G; Teyssier, JR	1
Bauer, U; Dittrich, C; Salzer, H; Sevelda, P; Vavra, N	1
Hino, K; Ibaraki, T; Katou, Y; Kiyozuka, Y; Maruyama, M; Nabuchi, K; Ninomiya, Y; Noda, T; Okamura, Y; Oku, M	1
Cohen, CJ; Dottino, PR; Goodman, HM; Kredentser, D; Rosenberg, M	1
Sou, S; Wakisaka, T	1
Bell, DR; Campbell, JC; Harnett, PR; Hillcoat, BL; Levi, JA; Rome, RM; Tattersall, MH; Woods, RL	1
Chambers, JT; Chambers, SK; Kohorn, EI; Schwartz, PE	1
Holthuis, JJ; Hulshoff, B; Mulder, NH; Postmus, PE; Sleijfer, DT; Van Oort, WJ; Verleun, H	1
Bugat, R; Canal, P; Carton, M; Michel, C; Soula, G	1
De Lena, M; Lorusso, V; Romito, S	1
Barlow, JJ; Lele, SB	1
Grospietsch, G; Hinney, B; Knappe, G; Kühnle, H; Rümelin, B; Temme, D	1
Piver, MS	1
Jordaan, JP; Maxwell, AM	1
Lele, SB; Malfetano, J; Piver, MS	1
Hilfrich, J; Kühnle, H	1
Grönroos, M; Kangas, L; Mäenpää, J	1
Bishop, JF; Campbell, JJ; Day, A; Hillcoat, BL; Pepperell, R; Quinn, MA	1

Reviews

41 review(s) available for etoposide and Ovarian Neoplasms

Article	Year
Pediatric growing teratoma syndrome of the ovary: A case report and review of the literature. Medicine, 2020, Sep-18, Volume: 99, Issue:38 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Female; Humans; Neoplasm Grading; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Salpingo-oophorectomy; Syndrome; Teratoma	2020
Growing teratoma syndrome after ovarian inmature teratoma: a case report and review of the literature. Clinical and experimental obstetrics & gynecology, 2016, Volume: 43, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Cytoreduction Surgical Procedures; Disease Progression; Douglas' Pouch; Etoposide; Female; Humans; Hysterectomy; Lymph Nodes; Lymphatic Metastasis; Neoplasm Grading; Neoplasm, Residual; Omentum; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Reoperation; Salpingectomy; Syndrome; Teratoma; Tomography, X-Ray Computed; Ultrasonography	2016
Ovarian dysgerminoma: a case report and literature review. Military medicine, 2013, Volume: 178, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Dysgerminoma; Etoposide; Female; Humans; L-Lactate Dehydrogenase; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Ovarian Neoplasms; Ovariectomy; Salpingectomy; Tomography, X-Ray Computed	2013
Effectiveness of chemotherapy in measurable granulosa cell tumors: a retrospective study and review of literature. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms; Retrospective Studies; Treatment Outcome; Vinblastine	2014
The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and overall survival in ovarian cancer. Gynecologic oncology, 2016, Volume: 140, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Polypharmacy; Randomized Controlled Trials as Topic; Survival Rate; Topotecan; Withholding Treatment; Young Adult	2016
Primary ovarian small cell carcinoma of pulmonary type with enlarged paraaortic lymph node masses: a case report and review of the literature. European journal of gynaecological oncology, 2012, Volume: 33, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms	2012
Presentation of two patients with malignant granulosa cell tumors, with a review of the literature. World journal of surgical oncology, 2012, Sep-11, Volume: 10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Granulosa Cell Tumor; Humans; Lymph Node Excision; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Review Literature as Topic; Tomography, X-Ray Computed; Treatment Outcome	2012
[Treatment of malignant ovarian germ cell tumor and sex cord tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Germinoma; Humans; Ovarian Neoplasms; Sex Cord-Gonadal Stromal Tumors; Vinblastine; Vincristine	2002
Splenic rupture from metastatic granulosa cell tumor 29 years after curative resection: case report and review of the literature. The American surgeon, 2003, Volume: 69, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Granulosa Cell Tumor; Humans; Hysterectomy; Middle Aged; Ovarian Neoplasms; Ovariectomy; Rupture, Spontaneous; Splenectomy; Splenic Neoplasms; Splenic Rupture; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2003
Growing teratoma syndrome vs chemotherapeutic retroconversion: case report and review of the literature. Gynecologic oncology, 2004, Volume: 92, Issue:1 Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Female; Humans; Ovarian Neoplasms; Pelvic Neoplasms; Syndrome; Teratoma	2004
[Treatment of platinum-resistant ovarian cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials as Topic; DNA Damage; Docetaxel; Drug Resistance, Neoplasm; Etoposide; Female; Gynecologic Surgical Procedures; Humans; Irinotecan; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Taxoids; Treatment Outcome	2004
Recurrent ovarian cancer: how important is it to treat to disease progression? Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Nov-15, Volume: 10, Issue:22 Topics: Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Disease Progression; Docetaxel; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Paclitaxel; Recurrence; Risk; Taxoids; Time Factors; Topotecan	2004
[Second-line chemotherapy for recurrent ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclophosphamide; Docetaxel; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Ovarian Neoplasms; Paclitaxel; Platinum; Taxoids	2005
Ovarian dysgerminoma and Apert syndrome. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Acrocephalosyndactylia; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chromosome Aberrations; Combined Modality Therapy; Dysgerminoma; Etoposide; Female; Humans; In Situ Hybridization, Fluorescence; Neoplasm Proteins; Neoplastic Syndromes, Hereditary; Nucleic Acid Hybridization; Ovarian Neoplasms; Ovariectomy; Point Mutation; Receptor, Fibroblast Growth Factor, Type 2; Remission Induction	2008
Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review. Archives of gynecology and obstetrics, 2008, Volume: 277, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Third; Teratoma	2008
Dysgerminoma in a child with ataxia-telangiectasia. Pediatric hematology and oncology, 2007, Volume: 24, Issue:6 Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Ataxia Telangiectasia; Biomarkers, Tumor; Bleomycin; CA-125 Antigen; Carboplatin; Child; Chorionic Gonadotropin, beta Subunit, Human; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Immunoglobulins, Intravenous; Neoplasm Proteins; Ovarian Neoplasms; Ovariectomy; Respiration Disorders	2007
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses]. Deutsche medizinische Wochenschrift (1946), 1981, Aug-28, Volume: 106, Issue:35 Topics: Bronchial Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Small Cell; Cell Division; Choriocarcinoma; Etoposide; Female; Humans; Leukemia; Liver Neoplasms; Lung Neoplasms; Male; Ovarian Neoplasms; Podophyllotoxin; Pregnancy; Testicular Neoplasms; Uterine Neoplasms	1981
Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecologic oncology, 1994, Volume: 55, Issue:3 Pt 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Humans; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Sex Cord-Gonadal Stromal Tumors	1994
[High-dose chemotherapy (HDCT) with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer patients with poor prognosis]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ovarian Neoplasms; Prognosis	1995
Advances in the chemotherapy of gynecologic cancer. Current opinion in oncology, 1994, Volume: 6, Issue:5 Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Endometrial Neoplasms; Etoposide; Female; Genital Neoplasms, Female; Germinoma; Humans; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Cervical Neoplasms	1994
7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials. Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl Topics: Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Survival; CHO Cells; Clinical Trials, Phase I as Topic; Cricetinae; DNA Topoisomerases, Type I; Drug Resistance; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Molecular Sequence Data; Neoplasms; Ovarian Neoplasms; Point Mutation; Topoisomerase I Inhibitors; Tumor Cells, Cultured	1994
Chronic etoposide administration: overview of clinical experience. Cancer treatment reviews, 1993, Volume: 19 Suppl C Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Drug Administration Schedule; Etoposide; Female; Germinoma; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms; Ovarian Neoplasms	1993
[Maintenance of the dose-intensity of chemotherapy combining carboplatin, cyclophosphamide, etoposide in women with ovarian cancer aged 70 and over]. Bulletin du cancer, 1996, Volume: 83, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Retrospective Studies; Survival Rate; Treatment Outcome	1996
[Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer]. Bulletin du cancer, 1996, Volume: 83, Issue:4 Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome	1996
[Chemotherapy for recurrent or advanced persistent epithelial ovarian cancer]. Harefuah, 1996, Volume: 131, Issue:1-2 Topics: Altretamine; Antineoplastic Agents; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Recurrence; Tamoxifen	1996
Avascular necrosis following extensive chemotherapy and dexamethasone treatment in a patient with advanced ovarian cancer: case report and review of the literature. Gynecologic oncology, 1996, Volume: 63, Issue:3 Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Papillary; Dexamethasone; Etoposide; Female; Humans; Middle Aged; Neoplasm, Residual; Osteonecrosis; Ovarian Neoplasms; Paclitaxel	1996
[Etoposide (VP-16) in gynecologic malignancy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:14 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Methotrexate; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine	1996
Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy. European journal of gynaecological oncology, 1997, Volume: 18, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Sertoli-Leydig Cell Tumor	1997
Future directions in the chemotherapy of ovarian cancer. Seminars in oncology, 1997, Volume: 24, Issue:5 Suppl 15 Topics: Administration, Oral; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Europe; Female; Forecasting; Gemcitabine; Humans; Injections, Intraperitoneal; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Time Factors; Topotecan; Vinblastine; Vinorelbine	1997
[Medical treatment of ovarian malignant germ cell tumors in the adult]. Bulletin du cancer, 1997, Volume: 84, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Humans; Neoplasm Staging; Ovarian Neoplasms; Radiotherapy Dosage; Survival Analysis; Treatment Outcome; Vinblastine	1997
Germ cell cancer. Current opinion in oncology, 1999, Volume: 11, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma in Situ; Child; Cisplatin; Etoposide; Female; Germinoma; Humans; Male; Ovarian Neoplasms; Salvage Therapy; Seminoma; Testicular Neoplasms	1999
Oral etoposide for the treatment of recurrent ovarian cancer. Drugs, 1999, Volume: 58 Suppl 3 Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms	1999
Dose-intensive approaches to ovarian cancer. Current oncology reports, 1999, Volume: 1, Issue:1 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Prognosis; Survival Analysis; Topotecan	1999
Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature. Gynecologic oncology, 2001, Volume: 81, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Dysgerminoma; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms	2001
Treatment of advanced ovarian cancer. European journal of cancer (Oxford, England : 1990), 2001, Volume: 37 Suppl 9 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Liposomes; Ovarian Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Topotecan	2001
The role of gemcitabine-based doublets in the management of ovarian carcinoma. Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carboplatin; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Paclitaxel; Topotecan; Vinblastine; Vinorelbine	2002
Developmental chemotherapy in advanced ovarian cancer: incorporation of newer cytotoxic agents in a phase III randomized trial of the Gynecologic Oncology Group (GOG-0182). Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Paclitaxel; Topotecan	2002
Epithelial ovarian cancer. Current treatment options in oncology, 2002, Volume: 3, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Combined Modality Therapy; Deoxycytidine; Docetaxel; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Practice Guidelines as Topic; Tamoxifen; Taxoids; Topotecan; Vinblastine; Vinorelbine	2002
New chemotherapies for ovarian cancer. Systemic and intraperitoneal podophyllotoxins. Cancer, 1991, Jan-01, Volume: 67, Issue:1 Suppl Topics: Combined Modality Therapy; Etoposide; Female; Humans; Injections, Intraperitoneal; Ovarian Neoplasms; Teniposide	1991
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma. Seminars in oncology, 1991, Volume: 18, Issue:1 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Cisplatin; Etoposide; Female; Humans; Infusions, Parenteral; Ovarian Neoplasms; Survival Rate; Thiosulfates	1991
[Treatment of advanced ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Ovarian Neoplasms; Postoperative Care; Prognosis; Survival Rate	1990

Trials

114 trial(s) available for etoposide and Ovarian Neoplasms

Article	Year
Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer. Medical oncology (Northwood, London, England), 2022, Sep-29, Volume: 39, Issue:12 Topics: Carcinoma, Ovarian Epithelial; Communicable Disease Control; COVID-19; Cytotoxins; Etoposide; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lymphoma, Follicular; Middle Aged; Ovarian Neoplasms; Prospective Studies; Sodium; Valproic Acid	2022
Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial. Gynecologic oncology, 2021, Volume: 162, Issue:2 Topics: Administration, Metronomic; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Indazoles; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progression-Free Survival; Pyrimidines; Quality of Life; Sulfonamides	2021
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study. The Lancet. Oncology, 2018, Volume: 19, Issue:9 Topics: Administration, Oral; Adolescent; Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Pyridines; Time Factors; Young Adult	2018
Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study. British journal of cancer, 2019, Volume: 121, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Etoposide; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Progression-Free Survival; Proportional Hazards Models; Survival Rate; Treatment Outcome; Young Adult	2019
Treatment outcomes of paclitaxel for refractory or recurrent epithelial ovarian cancer patients in Thailand. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Serous; Deoxycytidine; Drug Resistance, Neoplasm; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate	2013
Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503). Gynecologic oncology, 2015, Volume: 136, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Camptothecin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Taxoids; Young Adult	2015
Outcomes of ovarian germ cell tumors: ten years of experience at the Brazilian National Cancer Institute. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; United States; Young Adult	2015
Sex-Cord Stromal Tumors in Children and Teenagers: Results of the TGM-95 Study. Pediatric blood & cancer, 2015, Volume: 62, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Orchiectomy; Ovarian Neoplasms; Ovariectomy; Retrospective Studies; Salpingectomy; Sex Cord-Gonadal Stromal Tumors; Testicular Neoplasms	2015
Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Apr-10, Volume: 35, Issue:11 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prospective Studies; Risk Factors; Testicular Neoplasms	2017
Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Jul-01, Volume: 26, Issue:19 Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Deoxycytidine; Etoposide; Female; Gemcitabine; Germany; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Proportional Hazards Models; Quality of Life; Survival Rate; Topotecan; Treatment Outcome	2008
Venous thromboembolism in recurrent ovarian cancer-patients: A systematic evaluation of the North-Eastern German Society of Gynaecologic Oncology Ovarian Cancer Study Group (NOGGO). Thrombosis research, 2009, Volume: 124, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cohort Studies; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Germany; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Topotecan; Venous Thromboembolism	2009
Phase II study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancer. Journal of Korean medical science, 2009, Volume: 24, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Rate; Treatment Outcome	2009
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2010
Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study). International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Camptothecin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2011
Second-line treatment with intravenous gemcitabine and oral etoposide in platinum-resistant advanced ovarian cancer patients: results of a phase II study. Oncology, 2011, Volume: 80, Issue:3-4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Gemcitabine; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Survival Analysis; Treatment Outcome	2011
Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer. BMC cancer, 2011, Jul-11, Volume: 11 Topics: Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Platelets; Carboplatin; Cisplatin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Tamoxifen; Thrombocytopenia; Treatment Outcome	2011
Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution. World journal of surgical oncology, 2011, Oct-11, Volume: 9 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Dysgerminoma; Endodermal Sinus Tumor; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Retrospective Studies; Salvage Therapy; Survival Rate; Teratoma; Treatment Outcome; Young Adult	2011
Phase I clinical trial of alternating belotecan and oral etoposide in patients with platinum-resistant or heavily treated ovarian cancer. Anti-cancer drugs, 2012, Volume: 23, Issue:3 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Thrombocytopenia; Treatment Outcome	2012
Phase II study of oral etoposide and intravenous irinotecan for patients with platinum-resistant and taxane-pretreated ovarian cancer: Japan Clinical Oncology Group Study 0503. Japanese journal of clinical oncology, 2012, Volume: 42, Issue:3 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Camptothecin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infusions, Intravenous; Irinotecan; Ovarian Neoplasms; Research Design; Taxoids	2012
Prospective study of carboplatin-based chemotherapy for pediatric germ cell tumors. Medical and pediatric oncology, 2002, Volume: 39, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Etoposide; Female; Germinoma; Humans; Male; Neutropenia; Ovarian Neoplasms; Prospective Studies; Survival Analysis; Testicular Neoplasms; Treatment Outcome	2002
Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC). American journal of clinical oncology, 2003, Volume: 26, Issue:4 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; CA-125 Antigen; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum Compounds; Remission Induction; Survival Analysis	2003
Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. Journal of pediatric surgery, 2004, Volume: 39, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Humans; Infant; Neoplasm Staging; Ovarian Neoplasms; Survival Rate; Treatment Outcome	2004
Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer. International journal of clinical oncology, 2004, Volume: 9, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Etoposide; Feasibility Studies; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Survival Analysis; Transplantation, Autologous; Treatment Outcome	2004
Phase II study of ifosfamide plus daily oral etoposide in previously treated ovarian cancer: a Hoosier Oncology Group (HOG) study. American journal of clinical oncology, 2004, Volume: 27, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Analysis	2004
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jul-01, Volume: 22, Issue:13 Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Risk Factors; Testicular Neoplasms	2004
Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Sep-01, Volume: 22, Issue:17 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Germinoma; Humans; Male; Neutropenia; Ovarian Neoplasms; Testicular Neoplasms	2004
Sequential intraperitoneal topotecan and oral etoposide chemotherapy in recurrent platinum-resistant ovarian carcinoma: results of a phase II trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Sep-15, Volume: 10, Issue:18 Pt 1 Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma; Chromatography, High Pressure Liquid; Disease Progression; DNA; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Recurrence; Time Factors; Topotecan; Treatment Outcome	2004
Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group. Gynecologic oncology, 2004, Volume: 95, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Dysgerminoma; Etoposide; Female; Humans; Neoplasm Staging; Ovarian Neoplasms	2004
Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study. Gynecologic oncology, 2004, Volume: 95, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease Progression; Etoposide; Female; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies	2004
Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane. Results from a multicenter phase I/II study. Cancer, 2005, Apr-01, Volume: 103, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Drug Administration Schedule; Etoposide; Female; Humans; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platinum; Taxoids; Topotecan	2005
Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer. British journal of cancer, 2005, Mar-28, Volume: 92, Issue:6 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms	2005
Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma. Gynecologic oncology, 2005, Volume: 97, Issue:1 Topics: Adult; Antineoplastic Agents, Phytogenic; Cholesterol Esters; Emulsions; Etoposide; Female; Humans; Injections, Intravenous; Middle Aged; Oleic Acid; Ovarian Neoplasms; Receptors, LDL	2005
Paclitaxel, carboplatin, and oral etoposide as initial treatment for advanced ovarian carcinoma: a Minnie Pearl Cancer Research Network phase II trial. Gynecologic oncology, 2005, Volume: 97, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Paclitaxel	2005
[An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Edema; Etoposide; Female; Fever; Humans; Interleukin-11; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Platelet Count; Recombinant Proteins; Thrombocytopenia	2005
Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer. British journal of cancer, 2005, Jul-11, Volume: 93, Issue:1 Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Humans; Middle Aged; Organophosphorus Compounds; Ovarian Neoplasms; Quality of Life; Recurrence; Topotecan	2005
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948). British journal of cancer, 2005, Nov-28, Volume: 93, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Risk Assessment; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vincristine	2005
Sequential prolonged oral topotecan and prolonged oral etoposide as second-line therapy in ovarian or peritoneal carcinoma: a phase I Gynecologic Oncology Group study. Gynecologic oncology, 2006, Volume: 102, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Topotecan	2006
Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer. Bone marrow transplantation, 2006, Volume: 38, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Treatment Outcome	2006
Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis. Cancer, 2007, Feb-15, Volume: 109, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Humans; Infusions, Intra-Arterial; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Osmosis; Ovarian Neoplasms; Prospective Studies; Survival Rate	2007
Pilot study evaluating the efficacy and toxicity of irinotecan plus oral etoposide for platinum- and taxane-resistant epithelial ovarian cancer. Gynecologic oncology, 2007, Volume: 106, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Camptothecin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Pilot Projects; Taxoids	2007
[New antineoplastic drugs of the podophyllotoxin derivative group]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Jan-03, Volume: 38, Issue:1 Topics: Adult; Child; Clinical Trials as Topic; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms	1983
Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Germinoma; Humans; Middle Aged; Ovarian Neoplasms; Reoperation; Treatment Outcome	1994
A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary. Gynecologic oncology, 1994, Volume: 54, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Reoperation; Survival Rate; Vinblastine	1994
Reduction of the systemic toxicity of cisplatin by intra-arterial hepatic route administration for liver malignancies. International journal of cancer, 1995, Mar-03, Volume: 60, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Kidney Diseases; Leucovorin; Liver; Liver Neoplasms; Methotrexate; Neoplasms; Nervous System Diseases; Ovarian Neoplasms; Remission Induction; Spectrophotometry, Atomic; Tumor Cells, Cultured; Vinblastine	1995
Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support. Bone marrow transplantation, 1995, Volume: 15, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Digestive System; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Nervous System; Ovarian Neoplasms; Sarcoma; Survival Rate; Testicular Neoplasms; Transplantation, Autologous	1995
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:5 Topics: Administration, Topical; Adult; Aged; Antioxidants; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Cavity; Survival Rate; Thiosulfates	1995
Response to high-dose cisplatin and etoposide in advanced germ cell tumors in children: results of the Brazilian Germ Cell Tumor Study. Medical and pediatric oncology, 1995, Volume: 25, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brazil; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Infant; Male; Neoplasm Staging; Ovarian Neoplasms; Pilot Projects; Remission Induction; Reoperation; Testicular Neoplasms	1995
Maintenance chemotherapy with daily oral etoposide following salvage therapy in patients with germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:5 Topics: Administration, Oral; Bone Marrow Transplantation; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Germinoma; Hematologic Diseases; Humans; Male; Mediastinal Neoplasms; Ovarian Neoplasms; Remission Induction; Salvage Therapy	1995
The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial. Gynecologic oncology, 1995, Volume: 57, Issue:3 Topics: Aged; Altretamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Methotrexate; Mice; Mice, Inbred Strains; Middle Aged; Ovarian Neoplasms; Prospective Studies; Subrenal Capsule Assay; Tegafur	1995
Carboplatin (CBDCA)-hexamethylmelamine (HMM)-oral etoposide (VP-16) first-line treatment of ovarian cancer patients with bulky disease: a phase II study. Gynecologic oncology, 1995, Volume: 58, Issue:1 Topics: Administration, Oral; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms	1995
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Cancer, 1995, Feb-01, Volume: 75, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Enterocolitis; Etoposide; Female; Germinoma; Humans; Ifosfamide; Kidney; Male; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Pregnancy; Prognosis; Remission Induction; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Trophoblastic Neoplasms; Uterine Neoplasms	1995
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Tolerance; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Ovarian Neoplasms; Prognosis; Sarcoma; Testicular Neoplasms; Transplantation, Autologous	1995
A phase II trial of intraperitoneal high-dose carboplatin and etoposide with granulocyte macrophage-colony stimulating factor support in patients with ovarian carcinoma. American journal of clinical oncology, 1995, Volume: 18, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carboplatin; Carcinoma; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Parenteral; Ovarian Neoplasms; Survival Analysis; Thrombocytopenia; Treatment Outcome	1995
Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:7 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Remission Induction; Thrombocytopenia	1994
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignancies. Cancer, 1994, Jul-15, Volume: 74, Issue:2 Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infusions, Parenteral; Ovarian Neoplasms	1994
A comparison of intravenous versus intraperitoneal chemotherapy for the initial treatment of ovarian cancer. Gynecologic oncology, 1994, Volume: 54, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Remission Induction; Survival Analysis	1994
Phase II trial of etoposide, carboplatin, and ifosfamide as salvage therapy in advanced ovarian carcinoma. The Mount Sinai journal of medicine, New York, 1993, Volume: 60, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Treatment Outcome	1993
Escalating high-dose carboplatin and autologous bone marrow transplantation in solid tumors. Oncology, 1993, Volume: 50 Suppl 2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Germinoma; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Prospective Studies; Rhabdomyosarcoma; Transplantation, Autologous; Treatment Outcome	1993
Etoposide and carboplatin as salvage and first-line therapy in ovarian cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Remission Induction; Salvage Therapy; Thrombocytopenia	1993
Oral etoposide is active against platinum-resistant epithelial ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:1 Topics: Administration, Oral; Adult; Aged; Carcinoma; Drug Resistance; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum; Treatment Outcome	1994
Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease. British journal of cancer, 1994, Volume: 69, Issue:1 Topics: Administration, Oral; Adult; Aged; Carboplatin; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Epithelium; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Prospective Studies	1994
Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group study. Gynecologic oncology, 1993, Volume: 50, Issue:2 Topics: Adenocarcinoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Endometriosis; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Reoperation; Salvage Therapy; Treatment Outcome	1993
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors. Cancer research, 1993, Aug-15, Volume: 53, Issue:16 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Remission Induction; Retroperitoneal Neoplasms; Testicular Neoplasms	1993
A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide. British journal of cancer, 1993, Volume: 68, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Injections, Intraperitoneal; Kidney; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms	1993
The addition of etoposide and ifosfamide to cisplatin as second line therapy in ovarian carcinoma. European journal of gynaecological oncology, 1993, Volume: 14, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infusions, Intravenous; Mesna; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Treatment Outcome	1993
Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer. Gynecologic oncology, 1993, Volume: 49, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Injections, Intraperitoneal; Kidney; Middle Aged; Ovarian Neoplasms; Survival Rate; Thiosulfates	1993
Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstetrics and gynecology, 1996, Volume: 87, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Prospective Studies; Sertoli-Leydig Cell Tumor; Sex Cord-Gonadal Stromal Tumors; Survival Rate	1996
Clinical trial of daily low-dose oral etoposide for patients with residual or recurrent cancer of the ovary or uterus. Journal of obstetrics and gynaecology (Tokyo, Japan), 1995, Volume: 21, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Remission Induction; Uterine Neoplasms	1995
-Intravenous or oral etoposide therapy of platinum refractory ovarian cancer with early recurrence. Results of a prospective randomized study-. Geburtshilfe und Frauenheilkunde, 1996, Volume: 56, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Survival Rate; Treatment Outcome	1996
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481). European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14 Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Ovarian Neoplasms; Prodrugs	1995
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancer. American journal of obstetrics and gynecology, 1996, Volume: 174, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Drug Resistance; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Rate	1996
[Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer]. Bulletin du cancer, 1996, Volume: 83, Issue:4 Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome	1996
[Clinical trial of oral etoposide in the treatment of malignancies]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1995, Volume: 17, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Child; Etoposide; Female; Humans; Lung Neoplasms; Lymphoma; Male; Middle Aged; Ovarian Neoplasms; Prospective Studies	1995
Prophylactic granulocyte colony-stimulating factor allows escalation of chemotherapeutic dose intensity in advanced epithelial ovarian cancer. Gynecologic oncology, 1996, Volume: 63, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Middle Aged; Neutropenia; Ovarian Neoplasms; Thrombocytopenia	1996
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proceedings of the National Academy of Sciences of the United States of America, 1996, Dec-24, Volume: 93, Issue:26 Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Colony-Forming Units Assay; Cyclophosphamide; DNA Primers; Etoposide; Female; Genetic Therapy; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ovarian Neoplasms; Polymerase Chain Reaction	1996
High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological toxicities and role of growth factor administration. British journal of cancer, 1997, Volume: 75, Issue:8 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hematopoietic System; Humans; Length of Stay; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Recombinant Proteins; Survival Rate	1997
Phase II study of 96-hr continuous-infusion etoposide and doxorubicin with bolus cyclophosphamide in refractory epithelial ovarian cancer. Gynecologic oncology, 1997, Volume: 65, Issue:1 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections; Middle Aged; Ovarian Neoplasms; Salvage Therapy; Time Factors	1997
Effect of low-dose oral etoposide on serum CA-125 in patients with advanced epithelial ovarian cancer. Gynecologic oncology, 1997, Volume: 66, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; CA-125 Antigen; Carcinoma; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms	1997
[Efficacy of chemotherapy for clear cell adenocarcinoma of the ovary]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:10 Topics: Adenocarcinoma, Clear Cell; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Ovarian Neoplasms; Remission Induction	1997
Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Platinum Compounds	1998
Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:12 Topics: Adult; Aged; Antidotes; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Infusions, Parenteral; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Survival Analysis; Thiosulfates; Treatment Outcome	1997
Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors. Bone marrow transplantation, 1998, Volume: 21, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Ovarian Neoplasms; Recurrence; Retrospective Studies; Testicular Neoplasms; Transplantation, Autologous	1998
A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment. Gynecologic oncology, 1998, Volume: 69, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Prospective Studies; Reoperation; Survival Rate	1998
[Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:6 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Dexamethasone; Drug Therapy, Combination; Endometrial Neoplasms; Epirubicin; Etoposide; Female; Granisetron; Humans; Methylprednisolone; Middle Aged; Nausea; Ovarian Neoplasms; Uterine Neoplasms; Vomiting	1998
Disease-adapted relapse therapy for ovarian cancer: results of a prospective study. International journal of oncology, 1998, Volume: 13, Issue:1 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Prognosis; Prospective Studies; Recurrence; Time Factors	1998
[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13 Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Thrombocytopenia; Uterine Cervical Neoplasms	1998
Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study. Gynecologic oncology, 1999, Volume: 72, Issue:2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Granulosa Cell Tumor; Humans; Indiana; Middle Aged; Neoplasm Recurrence, Local; New York; North Carolina; Ovarian Neoplasms; Prospective Studies; Reoperation; Sex Cord-Gonadal Stromal Tumors; Treatment Outcome	1999
[Significance and effects of intraperitoneal cisplatin administration for ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Survival Analysis	1999
Phase I trial of carboplatin, paclitaxel, etoposide, and cyclophosphamide with granulocyte colony stimulating factor as first-line therapy for patients with advanced epithelial ovarian cancer. Gynecologic oncology, 2000, Volume: 77, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Taxoids; Thrombocytopenia; Treatment Outcome	2000
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone marrow transplantation, 2000, Volume: 25, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Carcinoma; Combined Modality Therapy; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Mesna; Middle Aged; Ovarian Neoplasms; Recombinant Proteins; Transplantation, Autologous	2000
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:5 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Salvage Therapy; Survival Analysis	2000
Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:16 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Thrombocytopenia	2000
The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Nov-15, Volume: 18, Issue:22 Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Child, Preschool; Chorionic Gonadotropin; Combined Modality Therapy; Etoposide; Female; Germinoma; Humans; Infant; Infant, Newborn; Male; Ovarian Neoplasms; Prognosis; Survival Analysis; Testicular Neoplasms	2000
Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma: a Gynecologic Oncology Group Study. American journal of clinical oncology, 2000, Volume: 23, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel	2000
High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results. Bone marrow transplantation, 2001, Volume: 27, Issue:10 Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Longitudinal Studies; Melphalan; Middle Aged; Ovarian Neoplasms; Survival Rate; Treatment Outcome	2001
Factors determining the actual received dose intensity in a program of multicyclic dose-intensive alternating chemotherapy with sequential stem cell support. Acta haematologica, 2001, Volume: 105, Issue:3 Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Count; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunomagnetic Separation; Middle Aged; Models, Biological; Ovarian Neoplasms; Paclitaxel; Stem Cells; Time Factors; Transplantation, Autologous; Treatment Outcome	2001
Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma. Gynecologic oncology, 2001, Volume: 83, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Epirubicin; Epithelial Cells; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Infusions, Parenteral; Laparotomy; Middle Aged; Mitoxantrone; Ovarian Neoplasms; Postoperative Care; Second-Look Surgery	2001
[Ifosfamide combination chemotherapy for advanced gynecologic malignancies]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2000, Volume: 22, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Treatment Outcome; Uterine Neoplasms	2000
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer. Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-125 Antigen; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Proteins; Ovarian Neoplasms; Ovariectomy; Survival Analysis; Transplantation, Autologous; Treatment Failure; Treatment Outcome	2001
A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study. Gynecologic oncology, 2002, Volume: 85, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Liposomes; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms	2002
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer. Journal of cancer research and clinical oncology, 1992, Volume: 119, Issue:1 Topics: Carboplatin; Cisplatin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Neutropenia; Ovarian Neoplasms	1992
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer. Gynecologic oncology, 1992, Volume: 47, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Etoposide; Female; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Salvage Therapy; Survival Rate	1992
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease? Seminars in oncology, 1992, Volume: 19, Issue:6 Suppl 14 Topics: Administration, Oral; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Resistance; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Ovarian Neoplasms	1992
A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:2-3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Injections, Intravenous; Leukopenia; Middle Aged; Ovarian Neoplasms	1992
High dose chemotherapy with cisplatin, VP16 and carboplatin with stem cell support in patients with advanced ovarian cancer. Haematologica, 1991, Volume: 76 Suppl 1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Ovarian Neoplasms; Pancytopenia; Transplantation, Autologous	1991
Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Infusions, Parenteral; Neoplasm Recurrence, Local; Ovarian Neoplasms; Retrospective Studies	1991
Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposide. Gynecologic oncology, 1991, Volume: 43, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Recurrence	1991
Pharmacologic study of etoposide and cisplatin by the intraperitoneal route. Journal of clinical pharmacology, 1991, Volume: 31, Issue:3 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Cisplatin; Drug Evaluation; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Male; Middle Aged; Ovarian Neoplasms	1991
A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Peritoneal Cavity	1991
[Clinical results of carboplatin in the treatment of malignant tumors. Clinical Cooperative Group of Carboplatin]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 1990, Volume: 12, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms	1990
Phase II clinical evaluation of etoposide (VP-16-213, Vepesid) as a second-line treatment in ovarian cancer. Results of the South-East European Oncology Group (SEEOG) Study. Oncology, 1990, Volume: 47, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Remission Induction	1990
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies	1989
[Carboplatin, VP-16 in epithelial ovarian cancer--initial experiences]. Gynakologische Rundschau, 1988, Volume: 28 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms	1988
Clinical trial of etoposide and cisplatin as salvage therapy in advanced ovarian carcinoma. Gynecologic oncology, 1987, Volume: 27, Issue:3 Topics: Adult; Aged; Carcinoma; Cisplatin; Clinical Trials as Topic; Cystadenocarcinoma; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms	1987

Other Studies

327 other study(ies) available for etoposide and Ovarian Neoplasms

Article	Year
Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum. Journal of natural products, 2001, Volume: 64, Issue:7 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Female; Humans; Ileal Neoplasms; KB Cells; Kidney Neoplasms; Lung Neoplasms; Magnetic Resonance Spectroscopy; Melanoma; Molecular Structure; Ovarian Neoplasms; Plant Leaves; Plant Stems; Plants, Medicinal; Stereoisomerism; Structure-Activity Relationship; Taiwan; Tumor Cells, Cultured; Vincristine	2001
Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir. Clinical research in cardiology : official journal of the German Cardiac Society, 2022, Volume: 111, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Cisplatin; Diagnostic Imaging; Etoposide; Female; Humans; Immunocompromised Host; Myocarditis; Ovarian Neoplasms; Parvoviridae Infections; Parvovirus B19, Human; Young Adult	2022
Formulation and Physicochemical and Biological Characterization of Etoposide-Loaded Submicron Emulsions with Biosurfactant of Sophorolipids. AAPS PharmSciTech, 2022, Jul-01, Volume: 23, Issue:6 Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Stability; Emulsions; Etoposide; Excipients; Female; Humans; Oleic Acids; Ovarian Neoplasms; Polysorbates; Surface-Active Agents; Triglycerides	2022
Extracranial germ cell tumours in children and adolescents: Results from the French TGM13 protocol. Pediatric blood & cancer, 2023, Volume: 70, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Child; Cisplatin; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Testicular Neoplasms	2023
[Matrix stiffening related lncRNA SNHG8 regulates chemosensitivity of ovarian cancer]. Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2023, Feb-25, Volume: 40, Issue:1 Topics: Cisplatin; Elasticity; Etoposide; Extracellular Matrix; Female; Humans; Ovarian Neoplasms; RNA, Long Noncoding	2023
Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study. Journal of gynecologic oncology, 2023, Volume: 34, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Conservative Treatment; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Paclitaxel; Pregnancy; Prognosis; Retrospective Studies; Young Adult	2023
How social media can help to understand treatment experiences of survivors of rare cancers: Findings from the Granulosa Cell Tumor Survivor Sisters Facebook group member survey. Cancer, 2023, 07-15, Volume: 129, Issue:14 Topics: Adult; Cisplatin; Etoposide; Female; Granulosa Cell Tumor; Humans; Ovarian Neoplasms; Social Media	2023
Fertility outcomes following surgery and multiagent chemotherapy in malignant ovarian germ cell tumor survivors: a survey study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2023, 11-06, Volume: 33, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Pregnancy; Surveys and Questionnaires; Survivors	2023
A 23-Year-Old Joradanian Woman with a Desmoplastic Small Round Cell Tumor Involving the Ovary. The American journal of case reports, 2019, Nov-14, Volume: 20 Topics: Abdominal Neoplasms; Abdominal Pain; Antineoplastic Combined Chemotherapy Protocols; Ascites; Biomarkers, Tumor; Cyclophosphamide; Desmoplastic Small Round Cell Tumor; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Jordan; Ovarian Neoplasms; Vincristine; Young Adult	2019
Malignant Sex Cord-Stromal Tumor, Not Otherwise Specified, Harboring FOXL2, p53, and TERT Promoter Mutations: Report of a Case. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2020, Volume: 39, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Forkhead Box Protein L2; Granulosa Cells; Humans; Middle Aged; Mutation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Promoter Regions, Genetic; Sex Cord-Gonadal Stromal Tumors; Tumor Suppressor Protein p53	2020
Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models. Scientific reports, 2019, 12-11, Volume: 9, Issue:1 Topics: Animals; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; DNA Damage; DNA-Activated Protein Kinase; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Polyethylene Glycols; Protein Kinase Inhibitors; Topoisomerase II Inhibitors; Tumor Burden; Xenograft Model Antitumor Assays	2019
Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1. British journal of cancer, 2020, Volume: 122, Issue:11 Topics: Antineoplastic Agents; Carboplatin; Cell Movement; Epithelial-Mesenchymal Transition; Etoposide; Female; Humans; Neoplastic Stem Cells; Ovarian Neoplasms; Zinc Finger Protein GLI1	2020
Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R). European journal of cancer (Oxford, England : 1990), 2020, Volume: 133 Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Feasibility Studies; Female; Fertility Agents, Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Menopause, Premature; Menstruation; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Pregnancy; Primary Ovarian Insufficiency; Republic of Korea; Retrospective Studies; Treatment Outcome; Young Adult	2020
Anlotinib combined with etoposide for platinum-resistant recurrent ovarian cancer: A case report. Medicine, 2020, Volume: 99, Issue:20 Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Indoles; Middle Aged; Ovarian Neoplasms; Quinolines	2020
Dose-intensive regimen treatment for small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT). Gynecologic oncology, 2020, Volume: 159, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cytoreduction Surgical Procedures; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Hypercalcemia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Ovary; Prospective Studies; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous; Young Adult	2020
Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1. European journal of pharmacology, 2021, Mar-15, Volume: 895 Topics: Antineoplastic Agents; Berberine; Carboplatin; Cell Line, Tumor; Cell Movement; Coculture Techniques; Epithelial-Mesenchymal Transition; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; Neoplastic Stem Cells; Ovarian Neoplasms; Polycomb Repressive Complex 1; Signal Transduction; Snail Family Transcription Factors; Vimentin; Zinc Finger Protein GLI1	2021
Effects of Palonosetron on Nausea and Vomiting Induced by Multiple-Day Chemotherapy: A Retrospective Study. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:4 Topics: Adult; Antiemetics; Antineoplastic Agents; Benzimidazoles; Bleomycin; Drug Therapy, Combination; Etoposide; Female; Granisetron; Humans; Male; Middle Aged; Nausea; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Palonosetron; Platinum Compounds; Retrospective Studies; Serotonin 5-HT3 Receptor Antagonists; Testicular Neoplasms; Vomiting	2021
Case Report: Ectopic Adrenocortical Carcinoma in the Ovary. Frontiers in endocrinology, 2021, Volume: 12 Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents; Bevacizumab; Cisplatin; Cytoreduction Surgical Procedures; Etoposide; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Ovary	2021
Establishment and characterization of an ovarian yolk sac tumor patient-derived xenograft model. Pediatric surgery international, 2021, Volume: 37, Issue:8 Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Disease Models, Animal; Endodermal Sinus Tumor; Etoposide; Female; Heterografts; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Transplantation, Heterologous; Xenograft Model Antitumor Assays	2021
Pregnancy and Delivery After Ovarian Yolk Sac Tumor: A Case Report. The American journal of case reports, 2021, Aug-19, Volume: 22 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Endodermal Sinus Tumor; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Pregnancy	2021
Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2017, Volume: 37, Issue:5 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Ovarian Epithelial; Etoposide; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Retrospective Studies; Survival Analysis; Turkey	2017
Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study. Pediatric blood & cancer, 2017, Volume: 64, Issue:11 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovariectomy; Prognosis; Prospective Studies; Survival Rate	2017
Efficacy of Pegylated Liposomal Doxorubicin in Low-Grade Serous Ovarian Carcinoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2017, Volume: 27, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cystadenocarcinoma, Serous; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Polyethylene Glycols; Retrospective Studies	2017
Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report. Journal of medical case reports, 2017, Dec-17, Volume: 11, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fertility Preservation; Humans; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Omentum; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Young Adult	2017
Neoadjuvant Bleomycin, Etoposide, and Cisplatin (BEP) Chemotherapy in the Treatment of Extensively Advanced Yolk Sac Tumors: A Single Center Experience. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:4 Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cytoreduction Surgical Procedures; Endodermal Sinus Tumor; Etoposide; Female; Humans; Neoadjuvant Therapy; Ovarian Neoplasms; Registries; Retrospective Studies; Young Adult	2018
An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:3 Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Retrospective Studies	2018
Apatinib and etoposide: surprising efficacy of an oral combination. The Lancet. Oncology, 2018, Volume: 19, Issue:9 Topics: Etoposide; Female; Humans; Ovarian Neoplasms; Platinum; Prospective Studies; Pyridines	2018
Growing teratoma syndrome in ovarian germ cell tumours - a diagnostic challenge, two case reports. JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:6 Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Cisplatin; Disease Progression; Etoposide; Female; Humans; Membrane Proteins; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Syndrome; Teratoma; Young Adult	2018
Outcomes of fertility-sparing surgery in ovarian juvenile granulosa cell tumor. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2019, Volume: 29, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Cisplatin; Etoposide; Female; Fertility Preservation; Granulosa Cell Tumor; Humans; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Treatment Outcome; Young Adult	2019
Multiple Cervical Root Resorption in a Young Adult Female Previously Treated with Chemotherapy: A Case Report. Journal of endodontics, 2019, Volume: 45, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cone-Beam Computed Tomography; Cyproterone Acetate; Dental Implantation; Dental Restoration, Permanent; Etoposide; Female; Humans; Ovarian Neoplasms; Root Resorption; Triptorelin Pamoate	2019
A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice. European journal of cancer (Oxford, England : 1990), 2019, Volume: 113 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Cisplatin; Cohort Studies; Dysgerminoma; Endodermal Sinus Tumor; Etoposide; Female; Gynecologic Surgical Procedures; Humans; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Teratoma; Treatment Outcome; Young Adult	2019
Phosphatidylinositol 3-kinases inhibitor LY294002 potentiates the cytotoxic effects of doxorubicin, vincristine, and etoposide in a panel of cancer cell lines. Fundamental & clinical pharmacology, 2014, Volume: 28, Issue:4 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Chromones; Doxorubicin; Drug Synergism; Enzyme Inhibitors; Etoposide; Female; Humans; Lung Neoplasms; Morpholines; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Vincristine	2014
CLC604 preferentially inhibits the growth of HER2-overexpressing cancer cells and sensitizes these cells to the inhibitory effect of Taxol in vitro and in vivo. Oncology reports, 2013, Volume: 30, Issue:4 Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal, Humanized; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Etoposide; Female; Furans; HSP90 Heat-Shock Proteins; Humans; Indazoles; Mice; Mice, SCID; Neoplasm Transplantation; Ovarian Neoplasms; Paclitaxel; Pyrazoles; Receptor, ErbB-2; Trastuzumab; Xenograft Model Antitumor Assays	2013
Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin. Annals of surgical oncology, 2014, Volume: 21, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cystadenocarcinoma, Serous; Etoposide; Female; Floxuridine; Follow-Up Studies; Heterozygote; Humans; Injections, Intraperitoneal; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Survival Rate; Topotecan	2014
Flagellate erythema. Dermatology online journal, 2013, Dec-16, Volume: 19, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Eruptions; Erythema; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Young Adult	2013
Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Feb-10, Volume: 32, Issue:5 Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Radiography; Risk Factors; Salvage Therapy; Time Factors; Treatment Outcome	2014
In vitro chemosensitivity assay of ascites in epithelial ovarian cancer. European journal of gynaecological oncology, 2013, Volume: 34, Issue:6 Topics: Antineoplastic Agents; Ascites; Carboplatin; Carcinoma, Ovarian Epithelial; Coloring Agents; Deoxycytidine; Disease Progression; Drug Screening Assays, Antitumor; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Survival Rate; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53	2013
[Small cell carcinoma of the ovary]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, Volume: 18, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Lymph Node Excision; Ovarian Neoplasms; Ovariectomy; Pelvic Pain; Radiotherapy, Adjuvant	2014
High-dose chemotherapy for recurrent ovarian germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Jan-10, Volume: 33, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Salvage Therapy; Stem Cell Transplantation; Treatment Outcome; Vinblastine	2015
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: a Taiwanese Gynecologic Oncology Group study. European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:18 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Organ Sparing Treatments; Ovarian Neoplasms; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult	2014
Clinical relevance of regulatory T cells monitoring in the peripheral blood of ovarian cancer patients. Human immunology, 2015, Volume: 76, Issue:2-3 Topics: Administration, Metronomic; Adult; Aged; Antineoplastic Agents; Blood Circulation; Carcinoma; Cyclophosphamide; Etoposide; Female; Humans; Immunophenotyping; Middle Aged; Monitoring, Immunologic; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Predictive Value of Tests; Prognosis; Prospective Studies; Sensitivity and Specificity; T-Lymphocytes, Regulatory; Treatment Outcome	2015
Mixed ovarian germ cell tumor composed of immature teratoma, yolk sac tumor and embryonal carcinoma. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2014, Volume: 24 Suppl 3 Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Chorionic Gonadotropin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Laparotomy; Neoplasms, Complex and Mixed; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovariectomy; Salpingostomy; Teratoma; Treatment Outcome; Young Adult	2014
[Patient receiving peritoneal dialysis after treatment of ovarian cancer]. Przeglad lekarski, 2014, Volume: 71, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Kidney Tubules; Ovarian Neoplasms; Peritoneal Dialysis; Peritoneal Neoplasms; Renal Insufficiency, Chronic	2014
Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour. European journal of cancer (Oxford, England : 1990), 2015, Volume: 51, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Endodermal Sinus Tumor; Etoposide; Female; Fertility Preservation; Gynecologic Surgical Procedures; Humans; Infant; Middle Aged; Organ Sparing Treatments; Ovarian Neoplasms; Retrospective Studies; Survival Analysis; Young Adult	2015
Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors. Gynecologic oncology, 2015, Volume: 137, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fertility Preservation; Humans; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Treatment Outcome	2015
Pharmacologically Increasing Mdm2 Inhibits DNA Repair and Cooperates with Genotoxic Agents to Kill p53-Inactivated Ovarian Cancer Cells. Molecular cancer research : MCR, 2015, Volume: 13, Issue:8 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cisplatin; Comet Assay; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; Etoposide; Female; Fibroblasts; HEK293 Cells; Humans; Imidazoles; Mice; Mice, Transgenic; Mutagens; Ovarian Neoplasms; Piperazines; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53	2015
Ovarian Cancer in Children and Adolescents: Treatment and Reproductive Outcomes. Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Female; Fertility; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Reproduction; Retrospective Studies; Survival Rate; Young Adult	2015
Outcome of patients with recurrent adult-type granulosa cell tumors--a Taiwanese Gynecologic Oncology Group study. Taiwanese journal of obstetrics & gynecology, 2015, Volume: 54, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulosa Cell Tumor; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Taiwan; Young Adult	2015
Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2015, Volume: 25, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility Preservation; Follow-Up Studies; Humans; Hysterectomy; Neoplasm Grading; Neoplasm Staging; Organ Sparing Treatments; Ovarian Neoplasms; Ovariectomy; Pregnancy; Pregnancy Rate; Retrospective Studies; Salpingectomy; Survival Rate; Teratoma; Vincristine; Young Adult	2015
Intensive cisplatin/oral etoposide for epithelial ovarian cancer: the Cambridge Gynae-Oncology Centre experience: too toxic for relapse? Anti-cancer drugs, 2016, Volume: 27, Issue:3 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Induction Chemotherapy; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms	2016
Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Feb-20, Volume: 34, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Child; Cisplatin; Disease-Free Survival; Etoposide; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Retroperitoneal Neoplasms; Risk Assessment; Survival Rate; Testicular Neoplasms; Vaginal Neoplasms; Vinblastine	2016
Chemotherapy is of Value in Second Line and Beyond, Relapsed High-grade, Serous Epithelial Ovarian Cancer: An Analysis of Outcomes Obtained With Oral Etoposide. American journal of clinical oncology, 2018, Volume: 41, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Serous; Etoposide; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies; Salvage Therapy; Survival Rate	2018
Recurrent 'growing teratoma syndrome' in an adolescent girl with a history of ovarian immature teratoma: A case report. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2016, Volume: 36, Issue:7 Topics: Adolescent; Antineoplastic Agents; Biopsy; Cisplatin; Disease Management; Etoposide; Female; Humans; Lymph Nodes; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Omentum; Ovarian Neoplasms; Ovariectomy; Teratoma; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography	2016
Decreased LRIG1 in Human Ovarian Cancer Cell SKOV3 Upregulates MRP-1 and Contributes to the Chemoresistance of VP16. Cancer biotherapy & radiopharmaceuticals, 2016, Volume: 31, Issue:4 Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Membrane Glycoproteins; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Up-Regulation	2016
Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma. The journal of obstetrics and gynaecology research, 2016, Volume: 42, Issue:11 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Salvage Therapy; Treatment Outcome; Young Adult	2016
Complications of dysgerminoma: meeting the health needs of patients in conflict zones. BMJ case reports, 2017, Jan-30, Volume: 2017 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Female; Foreign Bodies; Gastric Outlet Obstruction; Health Services Needs and Demand; Humans; Hydronephrosis; Lymph Node Excision; Ovarian Neoplasms; Sepsis; Tomography, X-Ray Computed; Warfare	2017
Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer. Gynecologic oncology, 2017, Volume: 145, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Audiometry, Pure-Tone; Bleomycin; Case-Control Studies; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Hearing Loss; Humans; Longitudinal Studies; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovariectomy; Platinum; Vinblastine; Young Adult	2017
[Bleomycin induced flagellate dermatitis: a new clinical case]. The Pan African medical journal, 2016, Volume: 25 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Erythema; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Ovarian Neoplasms	2016
[Clinical Study to Determine the Dose Intensity of BEP Chemotherapy for Ovarian Malignant Germ Cell Tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Treatment Outcome	2017
S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3. Oncology reports, 2008, Volume: 20, Issue:2 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blotting, Western; Calcium-Binding Proteins; Cell Proliferation; Epirubicin; Etoposide; Female; Fluorescent Antibody Technique; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Tumor Cells, Cultured	2008
Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecologic oncology, 2008, Volume: 111, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Endodermal Sinus Tumor; Etoposide; Female; Fertility; Gynecologic Surgical Procedures; Humans; Ovarian Neoplasms; Ovary; Retrospective Studies; Treatment Outcome	2008
Chemotherapy drug response in ovarian cancer cells strictly depends on a cathepsin D-Bax activation loop. Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:6 Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cathepsin D; Cell Line, Tumor; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Immunoblotting; Lysosomes; Membrane Potential, Mitochondrial; Microscopy, Fluorescence; Ovarian Neoplasms; Paclitaxel; Protein Transport; RNA Interference; Signal Transduction	2009
A case of ovarian endodermal sinus tumor diagnosed during pregnancy. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:5 Topics: Abortion, Induced; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bleomycin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Fatal Outcome; Female; Humans; Ovarian Neoplasms; Ovariectomy; Pregnancy; Pregnancy Trimester, First; Pulmonary Fibrosis	2008
Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol. Biological chemistry, 2008, Volume: 389, Issue:11 Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carboplatin; Cell Line, Tumor; Cisplatin; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Ovarian Neoplasms; Paclitaxel; RNA, Messenger	2008
Reduction in the size of a hepatic haemangioma after chemotherapy. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Endodermal Sinus Tumor; Etoposide; Female; Hemangioma; Humans; Hysterectomy; Liver Neoplasms; Magnetic Resonance Imaging; Neoplasms, Multiple Primary; Ovarian Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2008
Ovarian malignant immature teratoma associated with pregnancy--a case report. European journal of gynaecological oncology, 2008, Volume: 29, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cisplatin; Etoposide; Female; Humans; Laparoscopy; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Second; Teratoma; Ultrasonography, Prenatal	2008
Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman. International journal of clinical oncology, 2009, Volume: 14, Issue:1 Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Staging; Omentum; Ovarian Neoplasms; Ovariectomy; Rectum; Treatment Outcome	2009
Isolated breast metastasis from granulosa cell tumor of the ovary. Archives of gynecology and obstetrics, 2009, Volume: 280, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Female; Granulosa Cell Tumor; Humans; Hysterectomy; Middle Aged; Ovarian Neoplasms	2009
Survival after second-line intraperitoneal therapy for the treatment of epithelial ovarian cancer: the Gynecologic Oncology Group experience. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2009, Volume: 19, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Infusions, Parenteral; Interferon alpha-2; Interferon-alpha; Middle Aged; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Retrospective Studies; Survival Analysis; Thiotepa	2009
Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors. European journal of obstetrics, gynecology, and reproductive biology, 2009, Volume: 146, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Endodermal Sinus Tumor; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovariectomy; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult	2009
Growing teratoma syndrome: an Asian woman with immature teratoma of left ovary after chemotherapy. Taiwanese journal of obstetrics & gynecology, 2009, Volume: 48, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bleomycin; Cisplatin; Etoposide; Female; Humans; Imaging, Three-Dimensional; Lymph Node Excision; Omentum; Ovarian Neoplasms; Ovariectomy; Teratoma; Ultrasonography	2009
Familial small cell carcinoma of the ovary. Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7 Topics: Abdominal Pain; Adult; Age of Onset; Anticipation, Genetic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Diseases in Twins; Etoposide; Family Health; Female; Hormone Replacement Therapy; Humans; Hypercalcemia; Incidence; Menopause, Premature; Ovarian Neoplasms; Ovariectomy; Pedigree; Radiotherapy, Adjuvant; Remission Induction	2009
CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Gynecologic oncology, 2009, Volume: 115, Issue:3 Topics: Antineoplastic Agents, Alkylating; Apoptosis; CA-125 Antigen; Caspases; Cell Line, Tumor; Cisplatin; Cyclophosphamide; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Etoposide; Female; Humans; Immunoglobulin Fragments; Inhibitory Concentration 50; Ovarian Neoplasms	2009
[Clinicopathologic analysis of ovarian gonadoblastoma]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2009, Volume: 38, Issue:6 Topics: Adolescent; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Dysgerminoma; Etoposide; Female; Gonadoblastoma; Humans; Hysterectomy; Inhibins; Isoenzymes; Ovarian Neoplasms; Young Adult	2009
Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary. Acta obstetricia et gynecologica Scandinavica, 2009, Volume: 88, Issue:11 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Female; Humans; Lymphatic Metastasis; Ovarian Neoplasms; Peritoneal Neoplasms; Young Adult	2009
Efficient repair of DNA double-strand breaks in malignant cells with structural instability. Mutation research, 2010, Jan-05, Volume: 683, Issue:1-2 Topics: Antineoplastic Agents, Phytogenic; Antiviral Agents; Blotting, Southern; Chromosome Aberrations; Chromosome Painting; Cinnamates; DNA Breaks, Double-Stranded; DNA Repair; Drug Resistance, Neoplasm; Etoposide; Female; Ganciclovir; Humans; Hygromycin B; In Situ Hybridization, Fluorescence; Ovarian Neoplasms; Peptide Elongation Factor 1; Phosphotransferases (Alcohol Group Acceptor); Plasmids; Promoter Regions, Genetic; Thymidine Kinase; Tumor Cells, Cultured	2010
Oral etoposide for refractory or recurrent epithelial ovarian cancer. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2009, Volume: 92, Issue:11 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Survival Analysis; Treatment Outcome	2009
Growing teratoma syndrome of the ovary after fertility-sparing surgery and successful pregnancy. Gynecologic and obstetric investigation, 2010, Volume: 69, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Female; Humans; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Pregnancy; Teratoma	2010
Good prognosis for primary ovarian pure nongestational choriocarcinoma using the EMA/CO regime. European journal of gynaecological oncology, 2010, Volume: 31, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Ovarian Neoplasms; Prognosis; Vincristine; Young Adult	2010
Management of non-gestational ovarian choriocarcinoma: laparoscopy can be essential. Report of two cases. European journal of obstetrics, gynecology, and reproductive biology, 2010, Volume: 152, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma, Non-gestational; Cisplatin; Etoposide; Fatal Outcome; Female; Hexachlorocyclohexane; Humans; Laparoscopy; Middle Aged; Neoplasm Staging; Ovarian Neoplasms	2010
Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9). Gynecologic oncology, 2010, Volume: 119, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Retrospective Studies; Teratoma; Treatment Outcome; Young Adult	2010
Fertility in women after surgical treatment of nonepithelial ovarian tumors. Fertility and sterility, 2010, Volume: 94, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fertility; Humans; Hysterectomy; Infertility, Female; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovariectomy; Retrospective Studies; Young Adult	2010
Chemoresistance testing of human ovarian cancer cells and its in vitro model. Toxicology in vitro : an international journal published in association with BIBRA, 2010, Volume: 24, Issue:8 Topics: Antineoplastic Agents; Carboplatin; Carcinoma; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Gemcitabine; Humans; Models, Biological; Ovarian Neoplasms; Paclitaxel; Topotecan	2010
Ovarian small cell carcinoma, hypercalcemic type exhibiting a response to high-dose chemotherapy. South Dakota medicine : the journal of the South Dakota State Medical Association, 2010, Volume: 63, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Etoposide; Female; Genes, BRCA1; Humans; Hypercalcemia; Lymphatic Metastasis; Neoplasm Staging; Ovarian Neoplasms; Paraneoplastic Syndromes; Peripheral Blood Stem Cell Transplantation	2010
Outcomes after multiple lines of chemotherapy for platinum-resistant epithelial cancers of the ovary, peritoneum, and fallopian tube. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2011, Volume: 21, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; CA-125 Antigen; Carcinoma; Carcinoma, Ovarian Epithelial; Cisplatin; Cytotoxins; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fallopian Tube Neoplasms; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Platinum; Polyethylene Glycols; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome	2011
[Application of ATP-tumor chemosensitivity assay in recurrent epithelial ovarian cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:11 Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Deoxycytidine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Luminescent Measurements; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Topotecan	2010
Ovarian involvement of epithelioid trophoblastic tumor: a case report. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, 2011, Volume: 30, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunohistochemistry; Methotrexate; Neoplasms, Second Primary; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms	2011
Exploring palliative treatment outcomes in women with advanced or recurrent ovarian clear cell carcinoma. Gynecologic oncology, 2011, Volume: 122, Issue:1 Topics: Adenocarcinoma, Clear Cell; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Topotecan; Treatment Outcome	2011
Sex cord stromal tumors of the ovary in children: a clinicopathological report from the Italian TREP project. Pediatric blood & cancer, 2011, Jul-01, Volume: 56, Issue:7 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Ovarian Neoplasms; Prospective Studies; Sex Cord-Gonadal Stromal Tumors; Survival Rate; Treatment Outcome	2011
Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Jul-15, Volume: 17, Issue:14 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Proto-Oncogene Proteins c-jun; Signal Transduction; Sirolimus; Survival Analysis; TOR Serine-Threonine Kinases; Up-Regulation; Xenograft Model Antitumor Assays	2011
Fertility sparing surgery for ovarian tumors in children and young adults. Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Child; Cisplatin; Etoposide; Female; Fertility Preservation; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Organ Sparing Treatments; Ovarian Cysts; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Prospective Studies; Young Adult	2012
Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecologic oncology, 2012, Volume: 125, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Granulosa Cell Tumor; Gynecologic Surgical Procedures; Humans; Lymph Node Excision; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Pelvis; Recurrence; Registries; Retrospective Studies; Survival Analysis; Treatment Outcome	2012
Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype. Cell cycle (Georgetown, Tex.), 2012, May-15, Volume: 11, Issue:10 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma; Cell Differentiation; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Etoposide; Female; Fluorescent Antibody Technique, Indirect; Humans; Mesenchymal Stem Cells; Neoplasm Proteins; Neoplastic Stem Cells; Organic Chemicals; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured	2012
Ovarian germ cell neoplasm in a true hermaphrodite. Journal of the Indian Medical Association, 2011, Volume: 109, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disorders of Sex Development; Dysgerminoma; Etoposide; Female; Humans; Mosaicism; Ovarian Neoplasms	2011
Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database. The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Ovarian Neoplasms; Ovariectomy; Prognosis; Retrospective Studies; Sertoli-Leydig Cell Tumor; Treatment Outcome	2013
Normal serum CA125 half-life and normal serum nadir CA125 level in patients with ovarian cancers. European journal of gynaecological oncology, 2012, Volume: 33, Issue:3 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-125 Antigen; Camptothecin; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Cyclophosphamide; Docetaxel; Doxorubicin; Etoposide; Female; Half-Life; Humans; Irinotecan; Linear Models; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Reference Values; Remission Induction; Taxoids	2012
Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical Oncology. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Ovarian Epithelial; Etoposide; Female; Humans; Male; Medical Oncology; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Prognosis; Retrospective Studies; Salvage Therapy; Survival Rate	2012
Systemic thromboembolism after anti-cancer chemotherapy in a woman with ovarian germ cell tumor. The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:3 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Infarction; Cisplatin; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Thromboembolism	2013
[Treatment of recurrent ovarian cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 4 Topics: Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Deoxycytidine; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polyethylene Glycols; Reoperation; Topotecan	2012
Preoperative assessment of adnexal mass in adolescent patients. Akusherstvo i ginekologiia, 2012, Volume: 51 Suppl 1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CA-125 Antigen; Cisplatin; Etoposide; Female; Humans; Membrane Proteins; Ovarian Neoplasms; Ovary; Proteomics; Young Adult	2012
DNA damage causes TP53-dependent coupling of self-renewal and senescence pathways in embryonal carcinoma cells. Cell cycle (Georgetown, Tex.), 2013, Feb-01, Volume: 12, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Aurora Kinase B; Aurora Kinases; Autophagy; beta-Galactosidase; Cell Line, Tumor; Cellular Senescence; Checkpoint Kinase 2; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; DNA Repair; Embryonal Carcinoma Stem Cells; Etoposide; Female; G2 Phase Cell Cycle Checkpoints; Histones; Humans; Octamer Transcription Factor-3; Ovarian Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Rad51 Recombinase; RNA Interference; RNA, Small Interfering; Tumor Suppressor Protein p53; Up-Regulation	2013
Pure nongestational choriocarcinoma of the ovary: a case report. World journal of surgical oncology, 2013, Jan-15, Volume: 11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma, Non-gestational; Combined Modality Therapy; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Ovarian Neoplasms; Prognosis	2013
Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer. European journal of gynaecological oncology, 2002, Volume: 23, Issue:4 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Papillary; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Japan; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies	2002
Successful management of endodermal sinus tumor of the ovary associated with pregnancy. Gynecologic oncology, 2003, Volume: 88, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic	2003
EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs. Biochemical and biophysical research communications, 2003, Aug-01, Volume: 307, Issue:3 Topics: Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Carcinoma; DNA Topoisomerases, Type II; DNA-Binding Proteins; Down-Regulation; Doxorubicin; Drug Delivery Systems; Drug Therapy, Combination; Epstein-Barr Virus Nuclear Antigens; Etoposide; Female; G2 Phase; Genetic Therapy; Humans; Kinetics; Mitosis; Ovarian Neoplasms; Paclitaxel; Receptor, ErbB-2; Topoisomerase II Inhibitors; Tumor Cells, Cultured	2003
[Anaphylaxia induced by etoposide--a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:8 Topics: Adult; Anaphylaxis; Antineoplastic Agents, Phytogenic; Choriocarcinoma; Etoposide; Female; Humans; Ovarian Neoplasms	2003
Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission. Gynecologic oncology, 2003, Volume: 91, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Infusions, Parenteral; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Remission Induction; Treatment Outcome	2003
Ovarian endodermal sinus tumor in a 76-year-old woman. The journal of obstetrics and gynaecology research, 2003, Volume: 29, Issue:5 Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Fallopian Tube Neoplasms; Fatal Outcome; Female; Gynecologic Surgical Procedures; Humans; Ovarian Neoplasms	2003
[Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage I B and II A cervical cancer]. Akusherstvo i ginekologiia, 2003, Volume: 42, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Ovary; Treatment Outcome; Uterine Cervical Neoplasms	2003
Obstetric dilemma in an ovarian cancer patient. Acta obstetricia et gynecologica Scandinavica, 2004, Volume: 83, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Diagnosis, Differential; Endodermal Sinus Tumor; Etoposide; Fallopian Tubes; Female; Fertility; Humans; Ovarian Neoplasms; Ovariectomy; Pregnancy	2004
Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment. Gynecologic oncology, 2004, Volume: 92, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Doxorubicin; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prospective Studies; Quality of Life; Topotecan	2004
Stage IIIC small cell carcinoma of the ovary: survival with conservative surgery and chemotherapy. Obstetrics and gynecology, 2004, Volume: 103, Issue:5 Pt 2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fallopian Tubes; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Vinblastine	2004
Daily low-dose oral etoposide for recurrent epithelial ovarian cancer after platinum-based therapy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2004, Volume: 24, Issue:3 Topics: Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Cystadenocarcinoma, Papillary; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Iran; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Survival Analysis; Treatment Failure	2004
Usefulness of collagen gel droplet embedded culture drug sensitivity testing in ovarian cancer. Oncology reports, 2004, Volume: 12, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Culture Techniques; Cell Line, Tumor; Chemotherapy, Adjuvant; Cisplatin; Clinical Laboratory Techniques; Collagen; Disease Progression; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Gels; Humans; Irinotecan; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pharmaceutical Preparations; Recurrence; Remission Induction; Sensitivity and Specificity; Time Factors; Treatment Outcome	2004
The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecologic oncology, 2005, Volume: 97, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Docetaxel; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Sex Cord-Gonadal Stromal Tumors; Taxoids	2005
Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma. Toxicology and applied pharmacology, 2005, Dec-01, Volume: 209, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Kinetics; Leukocyte Count; Lung Neoplasms; Lymphocytes; Male; Micronuclei, Chromosome-Defective; Micronucleus Tests; Middle Aged; Ovarian Neoplasms; Paclitaxel	2005
Yolk sac tumor of the ovary during pregnancy: a case report. Gynecologic oncology, 2005, Volume: 99, Issue:2 Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ovarian Neoplasms; Peplomycin; Plant Lectins; Pregnancy; Pregnancy Complications, Neoplastic	2005
Human splicing factor SPF45 (RBM17) confers broad multidrug resistance to anticancer drugs when overexpressed--a phenotype partially reversed by selective estrogen receptor modulators. Cancer research, 2005, Aug-01, Volume: 65, Issue:15 Topics: Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Estrogen Receptor beta; Etoposide; Female; Humans; Mitoxantrone; Ovarian Neoplasms; Pyrrolidines; RNA Splicing; RNA Splicing Factors; RNA-Binding Proteins; RNA, Catalytic; Selective Estrogen Receptor Modulators; Tamoxifen; Thiophenes; Transfection	2005
NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780. International journal of oncology, 2005, Volume: 27, Issue:3 Topics: Anthracyclines; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Line, Tumor; Cell Survival; Disaccharides; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Female; Gene Expression; Humans; Multidrug Resistance-Associated Proteins; NF-kappa B; Nitriles; Ovarian Neoplasms; RNA, Messenger; Signal Transduction; Sulfones; Time Factors; Vinblastine	2005
Differential susceptibility to etoposide in clones derived from a human ovarian cancer cell line. Chemotherapy, 2006, Volume: 52, Issue:3 Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Apoptosis; Caspases; Cell Line, Tumor; Clone Cells; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction	2006
Cyclin A1 is a p53-induced gene that mediates apoptosis, G2/M arrest, and mitotic catastrophe in renal, ovarian, and lung carcinoma cells. Cellular and molecular life sciences : CMLS, 2006, Volume: 63, Issue:12 Topics: Apoptosis; CDC2 Protein Kinase; Cyclin A; Cyclin A1; Cyclin A2; DNA, Neoplasm; Etoposide; Female; G2 Phase; Gene Expression Profiling; Humans; Kidney Neoplasms; Lung Neoplasms; Mitosis; Mutation; Ovarian Neoplasms; Polyploidy; RNA, Messenger; RNA, Small Interfering; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation	2006
Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. International journal of cancer, 2006, Nov-15, Volume: 119, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Aurora Kinases; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Female; Fluorescent Antibody Technique; Humans; Immunoblotting; Immunoprecipitation; Ovarian Neoplasms; Paclitaxel; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Tumor Suppressor Protein p53	2006
[Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:12 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Follow-Up Studies; Humans; Infant; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Remission Induction; Survival Rate; Teratoma; Testicular Neoplasms; Treatment Outcome; Vincristine	2006
Yolk sac tumor of the ovary associated with endometrioid carcinoma with metastasis to the vagina: a case report. Gynecologic oncology, 2007, Volume: 105, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Endometrioid; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ovarian Neoplasms; Vaginal Neoplasms	2007
Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Gynecologic oncology, 2007, Volume: 105, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; China; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Multivariate Analysis; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Retrospective Studies; Salvage Therapy; Vinblastine	2007
Developmental chemotherapy and management of recurrent ovarian cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-15, Volume: 21, Issue:10 Suppl Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Doxorubicin; Drugs, Investigational; Enzyme Inhibitors; Etoposide; Female; Gemcitabine; Humans; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Recurrence; Research Design; Taxoids; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome	2003
Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy. Pediatric blood & cancer, 2008, Volume: 50, Issue:5 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Carcinoma, Small Cell; Celecoxib; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Imatinib Mesylate; Lymph Nodes; Lymphatic Metastasis; Ovarian Neoplasms; Piperazines; Pyrazoles; Pyrimidines; Sulfonamides; Thalidomide; Vinblastine	2008
Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum. Gynecologic oncology, 2008, Volume: 108, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Survival Rate	2008
[Evaluation of second-line chemotherapies most often used in recurrent epithelial ovarian cancer]. Orvosi hetilap, 2007, Dec-09, Volume: 148, Issue:49 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Middle Aged; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Topotecan; Treatment Outcome	2007
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Fertility; Humans; Neoplasm Staging; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Treatment Outcome	2008
Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation study. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Transplantation, Autologous	1984
Flow-cytophotometric studies on urine sediments of patients treated with anti-cancer-drugs. Urological research, 1983, Volume: 11, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Female; Flow Cytometry; Humans; Ifosfamide; Leukocytes; Male; Ovarian Neoplasms; Testicular Neoplasms; Urinary Bladder; Urine; Vinblastine	1983
High-dose cisplatin in hypertonic saline. Annals of internal medicine, 1984, Volume: 100, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Line; Cisplatin; Creatinine; Etoposide; Female; Fluid Therapy; Humans; Kidney Diseases; Male; Middle Aged; Ovarian Neoplasms; Prognosis; Saline Solution, Hypertonic; Testicular Neoplasms; Vinblastine	1984
Twenty years of anaplastic germ cell tumours. Journal of the Royal Society of Medicine, 1984, Volume: 77, Issue:1 Topics: Adult; alpha-Fetoproteins; Child; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Pregnancy; Prognosis; Testicular Neoplasms; Uterine Neoplasms	1984
Drug testing using a soft agar stem cell assay on patient and xenograft tumor material. International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:9 Topics: Animals; Antineoplastic Agents; Bleomycin; Cisplatin; Colony-Forming Units Assay; Drug Synergism; Etoposide; Female; Granulosa Cell Tumor; Humans; Melphalan; Methotrexate; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms; Ovarian Neoplasms; Transplantation, Heterologous; Tumor Stem Cell Assay; Vinblastine	1984
Etoposide single-agent chemotherapy for solid tumors. Cancer treatment reviews, 1982, Volume: 9 Suppl Topics: Carcinoma, Hepatocellular; Etoposide; Female; Head and Neck Neoplasms; Humans; Liver Neoplasms; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Sarcoma; Soft Tissue Neoplasms	1982
Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer. Gynecologic oncology, 1984, Volume: 17, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ovarian Neoplasms; Reoperation	1984
Data recycling and misreading: two potential errors in pooled data from small studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:9 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Communication; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Neoplasms; Ovarian Neoplasms; Research Design; Statistics as Topic; Uterine Neoplasms	1984
A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies. American journal of obstetrics and gynecology, 1984, Dec-15, Volume: 150, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dysgerminoma; Etoposide; Female; Humans; Mesonephroma; Ovarian Neoplasms	1984
Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patients. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Evaluation Studies as Topic; Female; Follow-Up Studies; Germinoma; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Ovariectomy; Reoperation; Survival Rate; Treatment Outcome; Vinblastine	1994
Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay. Cancer, 1994, Jun-01, Volume: 73, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; DNA; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Germinoma; Humans; Leukocytes; Male; Middle Aged; Ovarian Neoplasms; Platinum; Spectrophotometry, Atomic; Testicular Neoplasms; Vinblastine	1994
Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone marrow transplantation, 1994, Volume: 13, Issue:4 Topics: Adult; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Blood Transfusion, Autologous; Breast Neoplasms; Colony-Forming Units Assay; Cyclophosphamide; Etoposide; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Stem Cells; Humans; Immunologic Factors; Leukapheresis; Lymphoma, Non-Hodgkin; Middle Aged; Neutropenia; Ovarian Neoplasms	1994
Malignant germ cell tumors in childhood. Journal of surgical oncology, 1994, Volume: 56, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Etoposide; Female; Germinoma; Humans; India; Infant; Male; Methotrexate; Ovarian Neoplasms; Prognosis; Testicular Neoplasms; Treatment Outcome; Vinblastine	1994
Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience. Gynecologic oncology, 1994, Volume: 54, Issue:3 Topics: Adult; Anti-Mullerian Hormone; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carcinoembryonic Antigen; Cisplatin; Etoposide; Female; Glycoproteins; Growth Inhibitors; Humans; Inhibins; Liver Neoplasms; Ovarian Neoplasms; Sex Cord-Gonadal Stromal Tumors; Testicular Hormones	1994
Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks. Mutation research, 1994, Nov-01, Volume: 311, Issue:1 Topics: Antineoplastic Agents; Cell Survival; Chromosome Aberrations; DNA Damage; DNA, Neoplasm; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Mitomycin; Ovarian Neoplasms; Sister Chromatid Exchange; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1994
[Study on peripheral blood stem cells mobilized by different chemotherapies with granulocyte-colony stimulating factor in ovarian cancer]. Nihon Sanka Fujinka Gakkai zasshi, 1995, Volume: 47, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Ovarian Neoplasms; Prednimustine	1995
High-dose cisplatinum, vinblastine, bleomycin, and etoposide in the therapy of malignant nondysgerminomatous germ cell tumors of the ovary. Gynecologic oncology, 1995, Volume: 58, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Germinoma; Humans; Ovarian Neoplasms; Vinblastine	1995
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis. Blood, 1995, Jul-01, Volume: 86, Issue:1 Topics: Adult; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Breast Neoplasms; Cell Line; Chimera; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fibroblasts; Fluorouracil; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Interleukin-3; Lymphoid Tissue; Male; Mice; Mice, SCID; Middle Aged; Ovarian Neoplasms; Rats; Severe Combined Immunodeficiency; Testicular Neoplasms; Transplantation, Heterologous	1995
Etoposide protein binding in cancer patients. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents, Phytogenic; Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Protein Binding; Regression Analysis	1995
[A case of ovarian malignant Sertoli-Leidig cell tumor treated with CBDCA, etoposide and epirubicin chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Remission Induction; Sertoli-Leydig Cell Tumor	1995
Pediatric germ cell tumor. An experience with BEP. Journal of pediatric hematology/oncology, 1995, Volume: 17, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Male; Neoplasm Staging; Ovarian Neoplasms; Survival Analysis; Testicular Neoplasms	1995
Malignant germ cell tumours in two siblings. Medical and pediatric oncology, 1993, Volume: 21, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Child; Choriocarcinoma; Dysgerminoma; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Nuclear Family; Ovarian Neoplasms	1993
"Atypical" multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3). Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:3 Topics: Antineoplastic Agents; Catalysis; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Mitoxantrone; Ovarian Neoplasms; Tumor Cells, Cultured	1995
Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells. Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:1 Topics: Camptothecin; Carboplatin; Cisplatin; Cystadenocarcinoma, Serous; Drug Resistance; Drug Resistance, Multiple; Etoposide; Female; Glutathione; Glutathione Transferase; Humans; Ovarian Neoplasms; Tumor Cells, Cultured	1995
Intraperitoneal chemotherapy with cisplatin and etoposide in ovarian carcinoma patients who are clinically in complete remission. European journal of gynaecological oncology, 1995, Volume: 16, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Humans; Injections, Intraperitoneal; Middle Aged; Ovarian Neoplasms; Remission Induction; Survival Rate; Treatment Outcome	1995
Successful liver treatment of a juvenile granulosa cell tumor in a 4-year-old child by regional deep hyperthermia, systemic chemotherapy, and irradiation. Gynecologic oncology, 1995, Volume: 57, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Granulosa Cell Tumor; Humans; Hyperthermia, Induced; Ifosfamide; Liver Neoplasms; Ovarian Neoplasms; Ovariectomy; Ovary; Remission Induction; Temperature; Transaminases	1995
Onycholysis of the finger and toenails following the application of high-dose oral etoposide (1250 mg/m2) given as 200- and 150-mg single doses from days 1-10 every 3 weeks. Gynecologic oncology, 1995, Volume: 57, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fingers; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Nail Diseases; Ovarian Neoplasms; Toes	1995
Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation. Cancer, 1994, Jun-15, Volume: 73, Issue:12 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Line; DNA Topoisomerases, Type II; Drug Resistance; ErbB Receptors; Estrogens; Etoposide; Female; Heat-Shock Proteins; Humans; Membrane Glycoproteins; Neoplasm Proteins; Ovarian Neoplasms; Proteins; Proto-Oncogene Proteins; Receptor, ErbB-2; Receptors, Estrogen; RNA, Messenger; Trefoil Factor-1; Tumor Cells, Cultured; Tumor Suppressor Proteins; Vincristine	1994
Characterization of an etoposide-resistant human ovarian cancer cell line. Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:3 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Carrier Proteins; Drug Resistance; Etoposide; Female; Flow Cytometry; Gene Expression; Humans; Membrane Glycoproteins; Molecular Sequence Data; Neoplasm Proteins; Ovarian Neoplasms; Time Factors; Tumor Cells, Cultured	1994
[A case report: ovarian carcinoma IVth can become complete remission by immunochemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:13 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Infusion Pumps, Implantable; Neoplasm Staging; Ovarian Neoplasms; Picibanil; Remission Induction	1994
Busulfan-containing pre-transplant regimens for the treatment of solid tumors. Bone marrow transplantation, 1994, Volume: 14, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasms; Ovarian Neoplasms; Pilot Projects; Retrospective Studies; Sarcoma	1994
Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3. Oncology research, 1993, Volume: 5, Issue:8 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; DNA Damage; DNA, Neoplasm; DNA, Single-Stranded; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Mitoxantrone; Ovarian Neoplasms; Recombinant Proteins; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1993
Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer. Gynecologic oncology, 1994, Volume: 54, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Catheters, Indwelling; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Parenteral; Middle Aged; Mitoxantrone; Ovarian Neoplasms; Postoperative Complications; Reoperation; Retrospective Studies	1994
Carboplatin, etoposide, and ifosfamide as second-line treatment for ovarian cancer. American journal of clinical oncology, 1994, Volume: 17, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Remission Induction; Survival Rate	1994
Enhanced expression of HLA-A,B,C and inducibility of TAP-1, TAP-2, and HLA-A,B,C by interferon-gamma in a multidrug-resistant small cell lung cancer line. Lymphokine and cytokine research, 1994, Volume: 13, Issue:2 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 2; ATP Binding Cassette Transporter, Subfamily B, Member 3; ATP-Binding Cassette Transporters; Base Sequence; Breast Neoplasms; Carcinoma, Small Cell; Carrier Proteins; Cytotoxicity, Immunologic; DNA Primers; Drug Resistance; Etoposide; Female; Gene Expression; HLA Antigens; Humans; Interferon-gamma; Killer Cells, Lymphokine-Activated; Lung Neoplasms; Molecular Sequence Data; Ovarian Neoplasms; Recombinant Proteins; Tumor Cells, Cultured	1994
Multiple drug resistance in the human ovarian carcinoma cell line OAW42-A. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:8 Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Membrane Glycoproteins; Oligonucleotides, Antisense; Ovarian Neoplasms; Teniposide; Transfection; Tumor Cells, Cultured; Vincristine	1993
Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro. Cancer, 1993, Nov-01, Volume: 72, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; DNA, Neoplasm; Doxorubicin; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Female; Flow Cytometry; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured	1993
Circumvention of atypical multidrug resistance with tumor necrosis factor. Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:2 Topics: DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Drug Synergism; Etoposide; Female; Humans; Mitoxantrone; Ovarian Neoplasms; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1994
[Evaluation of prognostic nutritional index (PNI) as a prognostic indicator in multimodal treatment for gynecological cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Infusion Pumps, Implantable; Middle Aged; Nutrition Assessment; Ovarian Neoplasms; Prognosis; Survival Rate; Uterine Neoplasms	1994
[Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms	1993
Low-dose oral etoposide in epithelial cancer of the ovary. Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:6 Topics: Administration, Oral; Adult; Aged; Biological Availability; Carcinoma; Etoposide; Female; Humans; Middle Aged; Neutropenia; Ovarian Neoplasms; Remission Induction; Salvage Therapy	1993
Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimens. Gynecologic oncology, 1993, Volume: 50, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cohort Studies; Creatinine; Cyclophosphamide; Epithelium; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Parenteral; Kidney; Middle Aged; Neutropenia; Ovarian Neoplasms; Peritoneal Neoplasms; Treatment Outcome	1993
[Etoposide/cis-platinum (CDDP) combined chemotherapy for ovarian cancer: evaluation of optimum schedule for CDDP administration in chronic continuous exposure of ovarian cancer cells to low-dose etoposide in vitro]. Nihon Sanka Fujinka Gakkai zasshi, 1993, Volume: 45, Issue:2 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ovarian Neoplasms; Tumor Cells, Cultured	1993
Endometrioid carcinoma of the ovary. Retrospective study. European journal of gynaecological oncology, 1993, Volume: 14, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Endometriosis; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Medroxyprogesterone; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Retrospective Studies; Survival Rate; Tamoxifen	1993
[The value of etoposide (VP-16) in the therapy of refractory ovarian cancer]. Geburtshilfe und Frauenheilkunde, 1993, Volume: 53, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cause of Death; Cystadenocarcinoma; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate	1993
Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications. European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:8 Topics: Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Stem Cell Assay; Uterine Cervical Neoplasms	1993
Effect of the exposure dose of etoposide on the cell growth and cell kinetics of human ovarian cancer cells. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Etoposide; Female; G2 Phase; Humans; Ovarian Neoplasms; Time Factors; Tumor Cells, Cultured	1996
Microtubule effects of welwistatin, a cyanobacterial indolinone that circumvents multiple drug resistance. Molecular pharmacology, 1996, Volume: 49, Issue:2 Topics: Alkaloids; Antineoplastic Agents; Camptothecin; Cell Cycle; Cell Division; Cell Line; Cell Survival; Colchicine; Cyanobacteria; Cytoskeleton; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Resistance, Multiple; Etoposide; Female; GTP Phosphohydrolases; Humans; Indole Alkaloids; Kinetics; Microtubules; Muscle, Smooth, Vascular; Ovarian Neoplasms; Tubulin	1996
Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa. Gynecologic oncology, 1996, Volume: 61, Issue:3 Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Mixed Tumor, Mullerian; Ovarian Neoplasms; Survival Analysis; Treatment Outcome	1996
[The results of chemosensitivity test for clear cell adenocarcinoma of the ovary]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:7 Topics: Adenocarcinoma, Clear Cell; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Irinotecan; Mitomycin; Ovarian Neoplasms	1996
Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines. British journal of cancer, 1996, Volume: 74, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Interactions; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Ifosfamide; Ovarian Neoplasms; Paclitaxel; Tritium; Tumor Cells, Cultured	1996
Chemotherapy with doxorubicin, etoposide and cyclophosphamide (DEC) in ovarian cancer persistent after platinum-based treatment. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ovarian Neoplasms	1996
Chemotherapy for ovarian germ cell tumours. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Germinoma; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Salvage Therapy; Survival Rate; Vincristine	1996
Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines. Cytotechnology, 1996, Volume: 19, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Clone Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; HeLa Cells; Humans; Laryngeal Neoplasms; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Radiation Tolerance; Selection, Genetic; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vincristine	1996
Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Mesna; Middle Aged; Ovarian Neoplasms; Pilot Projects; Retroperitoneal Neoplasms; Testicular Neoplasms	1996
Endodermal sinus tumor and embryonal carcinoma of the ovary in a 53-year-old woman. Gynecologic oncology, 1996, Volume: 63, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Cisplatin; Diagnosis, Differential; Endodermal Sinus Tumor; Etoposide; Female; Germinoma; Humans; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms	1996
Activation of actin-cleavable interleukin 1beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer research, 1996, Nov-15, Volume: 56, Issue:22 Topics: Actins; Antineoplastic Agents; Apoptosis; Caspase 1; Cisplatin; Cysteine Endopeptidases; DNA Fragmentation; DNA, Neoplasm; Etoposide; Female; Humans; Ovarian Neoplasms; Protease Inhibitors; Time Factors; Tumor Cells, Cultured	1996
Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1996, Volume: 7, Issue:11 Topics: Antineoplastic Agents; Bleomycin; Bryostatins; Carcinoma; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Female; Head and Neck Neoplasms; Herpes Simplex Virus Protein Vmw65; Humans; Lactones; Lung Neoplasms; Macrolides; Ovarian Neoplasms; Paclitaxel; Phorbol 12,13-Dibutyrate; Protein Kinase C; Signal Transduction; Tumor Cells, Cultured	1996
[A case of poorly differentiated ovarian serous adenocarcinoma responding favorably to etoposide and cisplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:13 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma, Papillary; Drug Administration Schedule; Etoposide; Female; Humans; Ovarian Neoplasms	1996
[The usefulness of high dose etoposide for peripheral blood stem cell harvest]. Nihon Sanka Fujinka Gakkai zasshi, 1996, Volume: 48, Issue:11 Topics: Adult; Antineoplastic Agents, Phytogenic; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ovarian Neoplasms	1996
BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proceedings of the National Academy of Sciences of the United States of America, 1996, Nov-26, Volume: 93, Issue:24 Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Carboplatin; Cell Cycle; Cell Line; Cell Survival; Etoposide; Female; Humans; Hydroxyurea; Immunoblotting; Kinetics; Mice; Ovarian Neoplasms; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Transfection; Tumor Suppressor Protein p53; Vincristine	1996
"MECCA": a developmental, dose-intensive, non-cross-resistant platinum-based chemotherapy for advanced ovarian cancer. Gynecologic oncology, 1996, Volume: 63, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms	1996
Carboplatin in the combination chemotherapy of non-seminomatous germ cell tumours. Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Female; Germinoma; Humans; Male; Ovarian Neoplasms; Randomized Controlled Trials as Topic; Testicular Neoplasms	1996
Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer research, 1997, Mar-01, Volume: 57, Issue:5 Topics: Antineoplastic Agents; Cisplatin; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Female; Glutathione; Humans; Mitomycin; Ovarian Neoplasms; Paclitaxel; Regression Analysis; Tumor Cells, Cultured	1997
Salvage intraperitoneal therapy of advanced epithelial ovarian cancer: impact of retroperitoneal nodal disease. European journal of gynaecological oncology, 1997, Volume: 18, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carboplatin; Carcinoma; Cisplatin; Combined Modality Therapy; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Laparotomy; Lymphatic Metastasis; Middle Aged; Mitoxantrone; Neoplasm Staging; Ovarian Neoplasms; Retroperitoneal Space; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Outcome	1997
Abdominal wall metastases after surgical resection of an immature teratoma of the ovary. European journal of obstetrics, gynecology, and reproductive biology, 1997, Volume: 74, Issue:1 Topics: Abdominal Muscles; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Muscle Neoplasms; Neoplasm Staging; Ovarian Neoplasms; Teratoma	1997
Metastatic primitive neuroectodermal tumour of the ovary: successful treatment with mega-dose chemotherapy followed by peripheral blood progenitor cell rescue. Medical and pediatric oncology, 1997, Volume: 29, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Neuroectodermal Tumors, Primitive; Ovarian Neoplasms	1997
Advanced-stage small cell carcinoma of the ovary in pregnancy: long-term survival after surgical debulking and multiagent chemotherapy. Gynecologic oncology, 1997, Volume: 66, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Vinblastine	1997
Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer. Cancer, 1998, Feb-15, Volume: 82, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blotting, Western; Cisplatin; Cystadenocarcinoma, Mucinous; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome	1998
Secondary ANLL with t(11;19)(q23;p13) following etoposide and cisplatin for ovarian germ cell tumor. Indian journal of cancer, 1997, Volume: 34, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 19; Cisplatin; Etoposide; Female; Germinoma; Humans; Leukemia, Myeloid, Acute; Ovarian Neoplasms; Translocation, Genetic	1997
Ovarian germ cell tumors. European journal of gynaecological oncology, 1998, Volume: 19, Issue:2 Topics: Adolescent; Adult; Age Distribution; Aged; Anthramycin; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Etoposide; Female; Germinoma; Gynecologic Surgical Procedures; Humans; Incidence; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Palliative Care; Prognosis; Retrospective Studies; Spain; Survival Rate	1998
Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene, 1998, Apr-30, Volume: 16, Issue:17 Topics: Animals; Apoptosis; Cathepsin D; Cell Line; Colonic Neoplasms; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Fibroblasts; Genes, p53; Humans; Mice; Ovarian Neoplasms; Pepstatins; RNA, Messenger; Transcriptional Activation; Tumor Cells, Cultured; Up-Regulation	1998
[The role of glutathione and glutathione-S-transferase in neoplasm drug resistance]. Biulleten' eksperimental'noi biologii i meditsiny, 1998, Volume: 125, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dacarbazine; Drug Resistance, Neoplasm; Erythrocytes; Etoposide; Female; Glutathione; Glutathione Transferase; Humans; Male; Melanoma; Ovarian Neoplasms; Propionates; Skin Neoplasms; Testicular Neoplasms	1998
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study. Gynecologic oncology, 1998, Volume: 70, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Cisplatin; Etoposide; Female; Germinoma; Humans; Middle Aged; Ovarian Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine	1998
[Mobilization of peripheral blood stem cells in advanced ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:11 Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Component Removal; Cyclophosphamide; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Ovarian Neoplasms	1998
Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenctomy have similar survival to Stage I/II patients and superior survival to other Stage III patients. Cancer, 1998, Oct-15, Volume: 83, Issue:8 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Pelvis; Peritoneal Neoplasms; Prognosis; Survival Rate	1998
Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell lines. Biochemical pharmacology, 1999, Feb-15, Volume: 57, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Deoxycytosine Nucleotides; DNA Damage; Drug Synergism; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Ovarian Neoplasms; Tumor Cells, Cultured	1999
An active chemotherapy regimen for advanced ovarian sex cord-stromal tumors. Gynecologic oncology, 1999, Volume: 72, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Humans; Ovarian Neoplasms; Sex Cord-Gonadal Stromal Tumors	1999
Failure of high-dose chemotherapy with peripheral blood stem cell support for refractory placental site trophoblastic tumor. Gynecologic and obstetric investigation, 1999, Volume: 47, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Humans; Hysterectomy; Ovarian Neoplasms; Ovariectomy; Pregnancy; Transplantation, Autologous; Trophoblastic Tumor, Placental Site; Uterine Neoplasms	1999
Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. Cancer research, 1999, Jul-01, Volume: 59, Issue:13 Topics: Antigens, Neoplasm; Antineoplastic Agents; Carboplatin; Cell Survival; DNA Primers; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Genes, erbB-2; Humans; Isoenzymes; Models, Biological; Neoplasm Proteins; Neoplasm Staging; Ovarian Neoplasms; Polymerase Chain Reaction; Receptor, ErbB-2; RNA, Messenger; Survival Analysis; Time Factors; Transcription, Genetic; Tumor Cells, Cultured	1999
Schedule-dependent interactions between paclitaxel and etoposide in human carcinoma cell lines in vitro. Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:5 Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Division; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Time Factors; Tumor Cells, Cultured	1999
Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease-Free Survival; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Menstrual Cycle; Neoplasms, Second Primary; Ovarian Neoplasms; Ovariectomy; Pregnancy Rate; Retrospective Studies	1999
Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins. Oncogene, 2000, Jan-06, Volume: 19, Issue:1 Topics: Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Chlorambucil; DNA Damage; Drug Resistance, Neoplasm; Etoposide; Female; Humans; In Situ Nick-End Labeling; Mitochondria; Ovarian Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured	2000
[Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor]. Zhonghua fu chan ke za zhi, 1998, Volume: 33, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Germinoma; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Retrospective Studies	1998
Ovarian dysgerminoma with massive metastases to para-aortic lymph nodes. Gynecologic and obstetric investigation, 2000, Volume: 49, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Ovarian Neoplasms	2000
A novel combination of paclitaxel, etoposide, and cyclophosphamide for stem cell mobilization and tumor cytoreduction in ovarian cancer. Journal of hematotherapy & stem cell research, 2000, Volume: 9, Issue:2 Topics: Alopecia; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Transfusion; Carcinoma, Papillary; Cyclophosphamide; Endometrial Neoplasms; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Klebsiella Infections; Leukapheresis; Middle Aged; Neutropenia; Ovarian Neoplasms; Paclitaxel; Serous Membrane; Taxoids	2000
Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission. American journal of clinical oncology, 2000, Volume: 23, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Dysgerminoma; Endodermal Sinus Tumor; Etoposide; Female; Fertility; Follow-Up Studies; Germinoma; Humans; Leucovorin; Menstruation; Methotrexate; Ovarian Neoplasms; Remission Induction; Reproduction; Vincristine	2000
Novobiocin-induced VP-16 accumulation and MRP expression in human leukemia and ovarian carcinoma cells. Anti-cancer drug design, 2000, Volume: 15, Issue:2 Topics: Ascites; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Bone Marrow; Etoposide; Female; Humans; Kinetics; Leukemia; Multidrug Resistance-Associated Proteins; Novobiocin; Ovarian Neoplasms; Tumor Cells, Cultured	2000
High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results. Bone marrow transplantation, 2000, Volume: 26, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cystadenocarcinoma; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Laparotomy; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Reoperation; Retrospective Studies; Survival Rate; Time Factors; Transplantation, Autologous	2000
Advanced stage of dysgerminoma in testicular feminisation: is radical surgery necessary? The Australian & New Zealand journal of obstetrics & gynaecology, 2000, Volume: 40, Issue:2 Topics: Aged; Androgen-Insensitivity Syndrome; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disorders of Sex Development; Drug Administration Schedule; Dysgerminoma; Etoposide; Female; Humans; Male; Ovarian Neoplasms	2000
Endodermal sinus tumor in pregnancy. Gynecologic oncology, 2000, Volume: 78, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic	2000
Effect of cisplatin-based chemotherapy on emergence of cisplatin resistance, and its correlation with intracellular glutathione levels and accumulation of p53 protein in human ovarian cancer. Cancer biotherapy & radiopharmaceuticals, 2000, Volume: 15, Issue:3 Topics: Antineoplastic Agents; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Glutathione; Humans; Ovarian Neoplasms; Tumor Suppressor Protein p53	2000
Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer. European journal of gynaecological oncology, 2000, Volume: 21, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Recombinant Proteins	2000
Prognostic factors in platinum-resistant ovarian carcinoma treated with ifosfamide-etoposide. European journal of gynaecological oncology, 2000, Volume: 21, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Prognosis	2000
Ovarian mixed germ cell tumor composed of endodermal sinus tumor and immature teratoma: case report. Clinical and experimental obstetrics & gynecology, 2000, Volume: 27, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Endodermal Sinus Tumor; Etoposide; Female; Humans; Magnetic Resonance Imaging; Ovarian Neoplasms; Peplomycin; Teratoma	2000
A case of metastatic ovarian non-gestational choriocarcinoma: successful treatment with conservative type surgery and myeloablative chemotherapy. Pediatrics international : official journal of the Japan Pediatric Society, 2000, Volume: 42, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Child; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Treatment Outcome	2000
Metastatic carcinoma in a transposed ovary after radical hysterectomy for a stage 1B cervical adenosquamous cell carcinoma. Case report. European journal of gynaecological oncology, 2000, Volume: 21, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Ovarian Neoplasms; Ovariectomy; Ovary; Uterine Cervical Neoplasms	2000
Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:12 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Butylated Hydroxyanisole; Carcinogens; Cisplatin; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Flow Cytometry; Humans; Male; Ovarian Neoplasms; Oxides; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2000
Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University. European journal of gynaecological oncology, 2000, Volume: 21, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Egypt; Etoposide; Female; Follow-Up Studies; Germinoma; Humans; Neoplasm Staging; Ovarian Neoplasms; Reoperation; Retrospective Studies; Treatment Outcome	2000
Clear cell carcinoma of the ovary: a remarkable case. American journal of clinical oncology, 2001, Volume: 24, Issue:1 Topics: Adenocarcinoma, Clear Cell; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Female; Humans; Ovarian Neoplasms; Quality of Life; Topotecan	2001
Altretamine is an effective palliative therapy of patients with recurrent epithelial ovarian cancer. Japanese journal of clinical oncology, 2001, Volume: 31, Issue:2 Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Cystadenocarcinoma, Serous; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Prospective Studies; Topotecan	2001
Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells. Oncogene, 2001, Jun-14, Volume: 20, Issue:27 Topics: Bromodeoxyuridine; Cell Cycle; Centromere; Chromosomal Proteins, Non-Histone; DNA Damage; DNA Repair; DNA, Neoplasm; Etoposide; Female; Flow Cytometry; G2 Phase; Gamma Rays; HeLa Cells; Humans; Kinetics; Microfilament Proteins; Ovarian Neoplasms; Radiation Tolerance; Tumor Cells, Cultured	2001
[A case of pseudomyxoma peritonei treated successfully with intraperitoneal administration of CBDCA and etoposide, followed by local delivery of dextran with CDDP during surgery]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cystadenoma, Mucinous; Dextrans; Etoposide; Female; Humans; Hysterectomy; Injections, Intraperitoneal; Intraoperative Care; Laparotomy; Ovarian Neoplasms; Ovariectomy; Peritoneal Neoplasms; Pseudomyxoma Peritonei	2001
Primary ependymoma of the ovary, in which long-term oral etoposide (VP-16) was effective in prolonging disease-free survival. Gynecologic oncology, 2001, Volume: 83, Issue:1 Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Ovarian Neoplasms	2001
Immature teratoma of the ovary on fluid cytology. Diagnostic cytopathology, 2001, Volume: 25, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Biomarkers, Tumor; Bleomycin; Child; Cisplatin; Cytodiagnosis; Diagnosis, Differential; Etoposide; Female; Humans; Immunoenzyme Techniques; Lymphoma, Non-Hodgkin; Neuroblastoma; Ovarian Neoplasms; Rhabdomyosarcoma, Embryonal; Sarcoma, Ewing; Teratoma; Wilms Tumor	2001
Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line. Oncogene, 2002, Jan-03, Volume: 21, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Caspase 9; Caspases; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Female; Genes, Dominant; Genes, p53; Humans; Neoplasm Proteins; Oncogene Proteins, Viral; Ovarian Neoplasms; Poly(ADP-ribose) Polymerases; Recombinant Fusion Proteins; Repressor Proteins; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53	2002
Retreatment with dose-dense weekly cisplatin after previous cisplatin chemotherapy is not complicated by significant neuro-toxicity. European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nervous System Diseases; Ovarian Neoplasms; Prospective Studies; Regression Analysis; Retreatment; Salvage Therapy	2002
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:12 Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cisplatin; Cystadenocarcinoma, Serous; Etoposide; Female; Hematologic Diseases; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Survival Rate; Treatment Outcome	2001
Weekly platinum chemotherapy for recurrent ovarian cancer. British journal of cancer, 2002, Jan-07, Volume: 86, Issue:1 Topics: Administration, Oral; Antineoplastic Agents; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms	2002
Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer. British journal of cancer, 2002, Jan-07, Volume: 86, Issue:1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Prognosis	2002
[Globalization of anti-cancer therapies]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carboplatin; Cisplatin; Colorectal Neoplasms; Etoposide; Female; Humans; Irinotecan; Lung Neoplasms; Male; Neoplasms; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Stomach Neoplasms	2002
[Chemotherapy-associated myelosuppression in gynecological oncology]. Gynakologisch-geburtshilfliche Rundschau, 2001, Volume: 41, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cobalt Radioisotopes; Combined Modality Therapy; Cyclophosphamide; Data Interpretation, Statistical; Etoposide; Female; Fluorouracil; Hematopoiesis; Humans; Leukopoiesis; Lymph Node Excision; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Ovarian Neoplasms; Platelet Count; Radioisotope Teletherapy; Radiotherapy Dosage	2001
Recurrent ovarian cancer as chronic disease. Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Chronic Disease; Deoxycytidine; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Gemcitabine; Humans; Ovarian Neoplasms; Recurrence; Topotecan; Trastuzumab	2002
Sensitivity to anticancer agents and resistance mechanisms in clear cell carcinoma of the ovary. Japanese journal of cancer research : Gann, 2002, Volume: 93, Issue:6 Topics: Adenocarcinoma, Clear Cell; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cisplatin; Coloring Agents; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Etoposide; Female; Glutathione; Humans; Inhibitory Concentration 50; Irinotecan; Mitochondrial Proteins; Mitomycin; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; Ribosomal Proteins; RNA, Messenger; Saccharomyces cerevisiae Proteins; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	2002
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors]. Schweizerische medizinische Wochenschrift, 1975, Oct-18, Volume: 105, Issue:42 Topics: Adenocarcinoma; Bronchial Neoplasms; Carcinoma; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Remission, Spontaneous	1975
Teratomas of the ovary. British medical journal, 1979, May-05, Volume: 1, Issue:6172 Topics: Cisplatin; Drug Therapy, Combination; Etoposide; Female; Humans; Ovarian Neoplasms; Teratoma	1979
Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents. Gynecologic oncology, 1978, Volume: 6, Issue:1 Topics: Alkylating Agents; Alopecia; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Nausea; Ovarian Neoplasms; Podophyllotoxin; Vomiting	1978
Status report of Mayo Clinic studies. National Cancer Institute monograph, 1975, Volume: 42 Topics: Acrylates; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Middle Aged; Minnesota; Ovarian Neoplasms	1975
Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolin. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:1 Topics: Aphidicolin; Cell Survival; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Synergism; Etoposide; Female; Humans; Methotrexate; Mitosis; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay	1992
Modulation by D,L-buthionine-S,R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:8-9 Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Buthionine Sulfoximine; Carcinoma, Non-Small-Cell Lung; Cisplatin; Doxorubicin; Drug Synergism; Etoposide; Female; Glutathione; Humans; Lung Neoplasms; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil	1992
Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation. Japanese journal of cancer research : Gann, 1992, Volume: 83, Issue:11 Topics: Camptothecin; Cell Death; Cisplatin; DNA Damage; DNA, Neoplasm; Drug Synergism; Epirubicin; Etoposide; Female; Humans; Mitomycin; Ovarian Neoplasms; Recombinant Proteins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1992
Secondary leukaemias after etoposide. Lancet (London, England), 1992, Aug-08, Volume: 340, Issue:8815 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cystadenocarcinoma; Etoposide; Female; Humans; Leukemia, Monocytic, Acute; Middle Aged; Ovarian Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	1992
Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Cell Death; Cisplatin; Docetaxel; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Ovarian Neoplasms; Paclitaxel; Rhodamines; Taxoids; Tumor Cells, Cultured	1992
[Treatment of recurrent ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Parenteral; Lymph Node Excision; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ovariectomy; Paclitaxel	1992
Malignant ovarian germ cell tumors: the experience at the Hospital de la Santa Creu i Sant Pau. Gynecologic oncology, 1992, Volume: 45, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Menstruation; Methotrexate; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Reproduction; Retrospective Studies; Uterus; Vinblastine; Vincristine	1992
Ovarian germ cell malignancies: the Yale University experience. Gynecologic oncology, 1992, Volume: 45, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Salvage Therapy; Vinblastine; Vincristine	1992
The effect of retinoic acid on chemosensitivity of PA-1 human teratocarcinoma cells and its modulation by an activated N-ras oncogene. International journal of cancer, 1992, Jun-19, Volume: 51, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Line, Transformed; Cisplatin; Drug Interactions; Drug Screening Assays, Antitumor; Etoposide; Female; Fibronectins; Genes, ras; Humans; Ovarian Neoplasms; Teratoma; Transfection; Tretinoin	1992
[Recent advances in ovarian cancer chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Docetaxel; Doxorubicin; Etoposide; Female; Humans; Infusions, Parenteral; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Paclitaxel; Taxoids	1992
Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer. Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Glomerular Filtration Rate; Humans; Ifosfamide; Leukopenia; Middle Aged; Ovarian Neoplasms; Remission Induction; Survival Rate; Thrombocytopenia	1992
Expression of resistance to etoposide and vincristine in vitro and in vivo after X-irradiation of ovarian tumor cells. Anti-cancer drugs, 1992, Volume: 3, Issue:4 Topics: Animals; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Phenotype; Transplantation, Heterologous; Tumor Cells, Cultured; Vincristine	1992
Cisplatin in combination with continuous VP16 infusion as second line chemotherapy in ovarian carcinoma. A pilot study. European journal of gynaecological oncology, 1992, Volume: 13, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Pilot Projects; Recurrence; Treatment Outcome	1992
[Pharmacokinetics and toxicological study on the intraperitoneal administration of cisplatin and etoposide in gynecological malignancies]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:11 Topics: Adult; Aged; Anorexia; Bone Marrow; Cisplatin; Etoposide; Female; Humans; Infusions, Parenteral; Kidney; Middle Aged; Ovarian Neoplasms; Safety; Uterine Neoplasms	1992
[Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Carboplatin; Catheters, Indwelling; Drug Administration Schedule; Etoposide; Fallopian Tube Neoplasms; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Remission Induction	1992
[Intraperitoneal chemotherapy of metastatic ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:10 Suppl Topics: Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Stomach Neoplasms	1992
Combination chemotherapy tested in a short-term thymidine incorporation assay in primary cultures of ovarian adenocarcinomas. International journal of cell cloning, 1992, Volume: 10, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Ovarian Neoplasms; Thymidine; Tumor Cells, Cultured	1992
Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prospective Studies	1990
Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay. Gynecologic oncology, 1990, Volume: 39, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ovarian Neoplasms; Vincristine	1990
Treatment of malignant germ cell tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Survival Rate; Testicular Neoplasms	1990
Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin. Cancer research, 1991, Oct-01, Volume: 51, Issue:19 Topics: Bleomycin; Blotting, Western; Carmustine; Cisplatin; Cross Reactions; Dinitrochlorobenzene; DNA; DNA Repair; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Female; Gamma Rays; gamma-Glutamyltransferase; Glutathione; Glutathione Reductase; Glutathione Transferase; Humans; In Vitro Techniques; Methionine; Ovarian Neoplasms; Time Factors; Tumor Cells, Cultured; Vinblastine	1991
Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Dysgerminoma; Etoposide; Female; Follow-Up Studies; Humans; Ovarian Neoplasms; Reoperation; Survival Analysis; Vincristine	1991
Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy. Journal of cancer research and clinical oncology, 1992, Volume: 118, Issue:2 Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Female; Humans; Infusions, Parenteral; Laparotomy; Mitoxantrone; Ovarian Neoplasms; Retrospective Studies; Tissue Adhesions	1992
[Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrosarcoma; Fluorouracil; Leukemia P388; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Ovarian Neoplasms; Sarcoma, Experimental; Vindesine	1992
Ifosfamide and etoposide salvage treatment in advanced ovarian cancer. Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Salvage Therapy	1991
High dose chemotherapy for ovarian cancer. Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Etoposide; Female; Humans; Ovarian Neoplasms	1991
[Chemotherapy in malignant gynecologic tumors using intraperitoneal catheter with a subcutaneous reservoir]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cytodiagnosis; Drug Administration Schedule; Etoposide; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Reoperation; Uterine Neoplasms	1991
[Combination chemotherapy with cisplatin and etoposide for cerebellar metastasis from ovarian adenocarcinoma]. No shinkei geka. Neurological surgery, 1991, Volume: 19, Issue:8 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Remission Induction	1991
Lactobacillus septicemia, an unusual complication during the treatment of metastatic choriocarcinoma. Gynecologic oncology, 1991, Volume: 40, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Lactobacillus acidophilus; Methotrexate; Ovarian Neoplasms; Pregnancy; Sepsis; Uterine Neoplasms; Uterus; Vagina; Vincristine	1991
[Treatment of liver metastatic ovarian cancer with sequential administration of OK-432 and etoposide]. Nihon Gan Chiryo Gakkai shi, 1990, Dec-20, Volume: 25, Issue:12 Topics: Adult; Carcinoma, Hepatocellular; Etoposide; Female; Humans; Injections, Intravenous; Liver Neoplasms; Ovarian Neoplasms; Picibanil	1990
Carboplatin/etoposide as first-line chemotherapy in advanced ovarian carcinoma: a pilot study. Cancer chemotherapy and pharmacology, 1991, Volume: 27, Issue:5 Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Humans; Leukopenia; Middle Aged; Ovarian Neoplasms; Pilot Projects; Thrombocytopenia; Vomiting	1991
[The value of a Tenckhoff catheter in ovarian cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Catheters, Indwelling; Cisplatin; Etoposide; Evaluation Studies as Topic; Female; Humans; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms	1991
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]. Bulletin du cancer, 1990, Volume: 77, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Testicular Neoplasms	1990
Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer. Investigational new drugs, 1990, Volume: 8, Issue:2 Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Mesna; Middle Aged; Nausea; Ovarian Neoplasms; Sarcoma, Ewing; Testicular Neoplasms; Vomiting	1990
Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:6 Topics: Antibiotics, Antineoplastic; Camptothecin; Cell Line; Cisplatin; DNA Topoisomerases, Type I; Drug Interactions; Etoposide; Female; Humans; Naphthoquinones; Novobiocin; Ovarian Neoplasms; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1990
[Platinum-based combination chemotherapy for malignant mixed mesodermal tumor of the ovary: a case report]. Nihon Gan Chiryo Gakkai shi, 1990, Nov-20, Volume: 25, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Remission Induction	1990
[A carcinosarcoma of the ovary: a case report and a review]. Gan no rinsho. Japan journal of cancer clinics, 1990, Volume: 36, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinosarcoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Middle Aged; Ovarian Neoplasms	1990
[A case of recurrent ovarian cancer markedly responding to daily oral administration of low dose etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:11 Topics: Administration, Oral; Aged; Cystadenocarcinoma; Drug Administration Schedule; Etoposide; Female; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Remission Induction	1990
[Oral etoposide therapy in stage III-IV ovarian carcinoma]. Nihon Gan Chiryo Gakkai shi, 1990, Oct-20, Volume: 25, Issue:10 Topics: Administration, Oral; Adult; Aged; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Remission Induction	1990
[Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer]. Zentralblatt fur Gynakologie, 1990, Volume: 112, Issue:17 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Methotrexate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Peptichemio; Survival Rate	1990
A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Infusions, Parenteral; Ovarian Neoplasms; Remission Induction; Survival Analysis; Thiosulfates; Time Factors	1990
Phase II clinical trial of VP-16-213 (etoposide) administered orally in advanced ovarian cancer. Gynecologic oncology, 1990, Volume: 36, Issue:3 Topics: Administration, Oral; Adult; Aged; Dose-Response Relationship, Drug; Drug Evaluation; Etoposide; Female; Humans; Intestinal Absorption; Middle Aged; Ovarian Neoplasms	1990
A phase II study of etoposide combined with ifosfamide as second-line therapy in cisplatin-resistant ovarian carcinomas. Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms	1990
[Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:8 Pt 2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosyluracil; Carcinoma, Squamous Cell; Child; Cisplatin; Cystadenocarcinoma; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusion Pumps; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Teratoma	1990
[A case of stage III ovarian carcinoma successfully treated with oral etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:9 Topics: Adenocarcinoma; Administration, Oral; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Reoperation	1990
Small cell carcinoma of the ovary: a rapidly lethal tumor occurring in the young. Gynecologic oncology, 1985, Volume: 22, Issue:2 Topics: Adolescent; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Microscopy, Electron; Neoplasm Metastasis; Ovarian Neoplasms; Vinblastine; Vincristine	1985
High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:2 Topics: Adolescent; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Chorionic Gonadotropin; Cisplatin; Coccyx; Etoposide; Female; Humans; Infant; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Reoperation; Testicular Neoplasms; Vinblastine	1986
Etoposide, methotrexate, and bleomycin in drug-resistant gestational trophoblastic disease. Gynecologic oncology, 1986, Volume: 24, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms	1986
Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential for cure and preservation of reproductive capacity. Cancer, 1986, Dec-15, Volume: 58, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms	1986
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Male; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Risk; Testicular Neoplasms; Vinblastine	1987
Fertility after chemotherapy for ovarian germ cell tumours. British journal of obstetrics and gynaecology, 1987, Volume: 94, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Humans; Menstruation; Methotrexate; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Ovary; Vincristine	1987
Fertility after chemotherapy for male and female germ cell tumours. International journal of andrology, 1987, Volume: 10, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Female; Fertility; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Menstruation; Methotrexate; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Spermatogenesis; Testicular Neoplasms; Vincristine	1987
Chemotherapy of germ-cell ovarian tumours: first-line treatment with etoposide, bleomycin and cisplatin or carboplatin. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:5 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Child; Cisplatin; Etoposide; Female; Humans; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms	1987
Vinblastine, cisplatin, cyclophosphamide, bleomycin, doxorubicin, and etoposide in the treatment of small cell carcinoma of the ovary. Cancer, 1989, Sep-15, Volume: 64, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Remission Induction; Vinblastine	1989
Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer research, 1989, Aug-15, Volume: 49, Issue:16 Topics: Animals; Calcimycin; Cricetinae; Cricetulus; Dactinomycin; Deoxyglucose; Doxorubicin; Drug Resistance; Etoposide; Female; HSP70 Heat-Shock Proteins; Hypoxia; Membrane Proteins; Ovarian Neoplasms; Tumor Cells, Cultured; Vincristine	1989
Novel approaches to intraperitoneal drug delivery. Acta medica Austriaca, 1989, Volume: 16, Issue:3-4 Topics: Antineoplastic Agents; Dipyridamole; Dose-Response Relationship, Drug; Drug Evaluation; Drug Synergism; Etoposide; Female; Humans; Infusion Pumps; Infusions, Parenteral; Long-Term Care; Methotrexate; Ovarian Neoplasms; Peritoneal Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay	1989
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms	1989
[Clinical application of subrenal capsule assay in ovarian cancer]. Nihon Sanka Fujinka Gakkai zasshi, 1989, Volume: 41, Issue:12 Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Mice; Mice, Inbred Strains; Middle Aged; Ovarian Neoplasms; Predictive Value of Tests; Remission Induction; Subrenal Capsule Assay; Survival Rate	1989
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience). Acta medica Austriaca, 1989, Volume: 16, Issue:3-4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Mitoxantrone; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms	1989
A new combination chemotherapy for the treatment of endodermal sinus tumour. The Australian & New Zealand journal of obstetrics & gynaecology, 1989, Volume: 29, Issue:3 Pt 2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Injections, Intravenous; Mesonephroma; Ovarian Neoplasms; Vinblastine; Vincristine	1989
High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancer. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms	1989
Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole. Cancer research, 1989, Jun-15, Volume: 49, Issue:12 Topics: Animals; Cell Line; Cell Survival; Colony-Forming Units Assay; Dipyridamole; Doxorubicin; Drug Synergism; Etoposide; Female; Humans; Kinetics; Ovarian Neoplasms; Tumor Stem Cell Assay; Vinblastine	1989
First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer. British journal of cancer, 1989, Volume: 60, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms	1989
Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line. International journal of cancer, 1989, Mar-15, Volume: 43, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Chromosome Deletion; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Mice; Mice, Nude; Ovarian Neoplasms; Phenotype; Tumor Cells, Cultured; Verapamil; Vincristine	1989
[A case report of an advanced ovarian cancer (stage T4) treated with a total amount of 1815 mg of CDDP]. Gan no rinsho. Japan journal of cancer clinics, 1987, Volume: 33, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Mitomycin; Mitomycins; Ovarian Neoplasms	1987
[A case of recurrent ovarian cancer successfully treated with etoposide]. Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:5 Topics: Adenocarcinoma; Administration, Oral; Combined Modality Therapy; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Pelvic Neoplasms; Reoperation	1988
Cisplatin plus VP 16-213 in advanced ovarian carcinoma. Gynecologic oncology, 1988, Volume: 30, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma; Cisplatin; Depression, Chemical; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Time Factors	1988
Etoposide (VP-16-213) plus cis-diamminedichloroplatinum as salvage therapy in advanced epithelial ovarian cancer. Gynecologic oncology, 1987, Volume: 27, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Epithelium; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms	1987
Pharmacokinetics of high dose etoposide (VP 16-213). European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Saliva; Testicular Neoplasms	1986
Quantification of teniposide in human serum by high-performance liquid chromatography with electrochemical detection. Journal of chromatography, 1986, Mar-07, Volume: 375, Issue:2 Topics: Carcinoma; Chromatography, High Pressure Liquid; Electrochemistry; Etoposide; Female; Humans; Indicators and Reagents; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Time Factors	1986
Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma. Cancer treatment reports, 1986, Volume: 70, Issue:7 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Hematologic Diseases; Humans; Middle Aged; Nausea; Neoplasm Staging; Ovarian Neoplasms	1986
Etoposide (VP-16) plus cisplatin (DDP): a new active chemotherapeutic combination in patients with stage III-IV ovarian adenocarcinoma. Journal of surgical oncology, 1986, Volume: 32, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Etoposide; Female; Humans; Middle Aged; Ovarian Neoplasms; Podophyllotoxin; Prognosis	1986
[Postoperative therapy of epithelial ovarian cancer at the Göttingen University Gynecologic Clinic. A retrospective analysis of 82 patients 1981-1984]. Geburtshilfe und Frauenheilkunde, 1986, Volume: 46, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Reoperation	1986
"Cisplatin plus etoposide as second-line treatment in advanced ovarian carcinoma". Cancer treatment reports, 1986, Volume: 70, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms	1986
Treatment for recurrent ovarian cancer. A report of 2 cases. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1987, Feb-07, Volume: 71, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms	1987
Cisplatin plus VP16-213 in refractory ovarian carcinoma. American journal of clinical oncology, 1987, Volume: 10, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Ovarian Neoplasms	1987
[Chemotherapy of advanced ovarian cancer. Göttingen-Hannover studies]. Onkologie, 1985, Volume: 8, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Reoperation	1985
Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I. Obstetrics and gynecology, 1985, Volume: 66, Issue:5 Topics: Aclarubicin; Adolescent; Adult; Aged; Altretamine; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Methotrexate; Mice; Middle Aged; Mitomycins; Naphthacenes; Neoplasm Transplantation; Ovarian Neoplasms; Tegafur; Tumor Stem Cell Assay; Vincristine	1985
Phase II trial of VP-16-213 in advanced ovarian carcinoma. Gynecologic oncology, 1985, Volume: 22, Issue:2 Topics: Administration, Oral; Aged; Carcinoma; Cisplatin; Cystadenocarcinoma; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Parenteral; Middle Aged; Nausea; Ovarian Neoplasms; Podophyllotoxin; Vomiting	1985